≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Herpesviral [herpes simplex] infections

EFO Endpoint Browser PheWeb

AB1_HERPES_SIMPLEX

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — B00
  • Hospital discharge: ICD-9 — 05[4]
  • Hospital discharge: ICD-8 — 05[4]
  • Hospital discharge: excluded ICD-9 — 0541A
  • Hospital discharge: excluded ICD-8 — 0540[2]
  • Cause of death: ICD-10 — B00
  • Cause of death: ICD-9 — 05[4]
  • Cause of death: ICD-8 — 05[4]
  • Cause of death: excluded ICD-9 — 0541A
  • Cause of death: excluded ICD-8 — 0540[2]

2 out of 7 registries used, show all original rules.

4867

4. Check minimum number of events

None

4867

5. Include endpoints

None

4867

6. Filter based on genotype QC (FinnGen only)

4867

Control definitions (FinnGen only)

Control exclude
AB1_VIRAL_SKIN_MUCOUS_MEMBRANE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 37387 21787 15388
Only index persons 33592 20093 13499
Unadjusted period prevalence (%)
Whole population 0.54 0.62 0.43
Only index persons 0.65 0.74 0.52
Median age at first event (years)
Whole population 41.45 42.64 39.62
Only index persons 40.80 42.22 38.70

-FinnGen-

Key figures

All Female Male
Number of individuals 4867 3228 1639
Unadjusted period prevalence (%) 0.97 1.10 0.72
Median age at first event (years) 48.60 46.03 53.68

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
4343
Matched controls
43428
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J05AB01
ATC
aciclovir; systemic
11.0
323.0
2611
5248
H03.1*B00.5
ICD-10 Finland
Herpesviral dermatitis of eyelid
+∞
323.0
480
*
J05AB11
ATC
valaciclovir; oral
8.9
323.0
1652
2790
S01AD03
ATC
aciclovir; ophthalmic
59.1
323.0
1688
462
H19.1*B00.5
ICD-10 Finland
Herpesviral keratoconjunctivitis
+∞
323.0
1178
*
B00.10
ICD-10 Finland
Herpes simplex facialis
115.7
323.0
564
56
B00.19
ICD-10 Finland
Other vesicular dermatitis caused by the herper simplex virus
220.7
323.0
437
22
B00.11
ICD-10 Finland
Herpes simplex labialis
33.3
323.0
468
157
B00.5
ICD-10 Finland
Herpesviral ocular disease
346.0
287.5
288
9
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
175.3
267.5
279
17
B00.9
ICD-10 Finland
Herpesviral infection, unspecified
70.8
226.3
260
39
H19.1
ICD-10 Finland
Herpesviral keratitis and keratoconjunctivitis
87.9
201.5
225
27
H13.1*B00.5
ICD-10 Finland
Herpesviral conjunctivitis
+∞
158.3
151
*
D06BB03
ATC
aciclovir; topical
5.5
152.1
484
963
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.4
150.1
2016
11649
05405
ICD-8 Finland
Herpes simplex, Kerato-conjunctivitis herpetica
+∞
128.8
123
*
B00.1
ICD-10 Finland
Herpesviral vesicular dermatitis
25.6
128.4
182
74
H16.9
ICD-10 Finland
Keratitis, unspecified
11.1
126.4
248
235
05401
ICD-8 Finland
Herpes simplex, Gingivostomatitis
+∞
123.5
118
*
B00.0
ICD-10 Finland
Eczema herpeticum
31.3
119.2
160
53
H16.0
ICD-10 Finland
Corneal ulcer
5.0
114.4
397
862
B02.9
ICD-10 Finland
Zoster without complication
6.0
112.5
330
588
H02AB06
ATC
prednisolone; systemic
2.1
110.7
2155
14026
G05.1*B00.4
ICD-10 Finland
Herpesviral meningoencephalitis
+∞
108.8
104
*
L20.0
ICD-10 Finland
Besnier prurigo
3.6
100.0
493
1482
H04.10
ICD-10 Finland
Dry eye syndrome
3.1
99.9
612
2167
H19.2*B02.3
ICD-10 Finland
Keratitis and keratoconjunctivitis (interstitial) in zoster
969.7
97.4
95
*
H22.0*B00.5
ICD-10 Finland
Herpesviral iridocyclitis
+∞
87.8
84
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
87.7
1814
11713
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
8.5
85.8
195
240
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.0
82.7
1495
9118
J01DB01
ATC
cefalexin; oral
2.1
81.8
3592
30122
B00.8
ICD-10 Finland
Other forms of herpesviral infection
75.8
78.4
89
12
G02.0*B00.3
ICD-10 Finland
Herpesviral meningitis
+∞
78.4
75
*
H03.1*B02.3
ICD-10 Finland
Zoster blepharitis
+∞
78.4
75
*
D07AA02
ATC
hydrocortisone; topical
2.4
77.4
752
3473
0542A
ICD-9 Finland
Herpes simplex, Herpetic gingivostomatitis[GINGIVOSTOMATITIS HERPETICA]
+∞
75.2
72
*
E0000UV
ATC
NA
1.8
72.8
1797
12099
B02.3
ICD-10 Finland
Zoster ocular disease
243.9
70.5
72
*
H03.1
ICD-10 Finland
Involvement of eyelid in other infectious diseases classified elsewhere
84.8
67.1
75
9
R50.9
ICD-10 Finland
Fever, unspecified
2.3
66.6
686
3237
E000001
ATC
NA
2.0
64.7
993
5579
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.5
63.4
555
2406
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
4.1
63.3
260
660
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.2
62.6
773
3960
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
3.2
61.9
356
1187
D11AH01
ATC
tacrolimus; topical
9.7
61.4
128
136
E000002
ATC
NA
2.3
58.4
597
2793
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.6
57.6
453
1845
D07AC01
ATC
betamethasone; topical
1.7
54.7
1449
9726
D11AX14
ATC
[U] tacrolimus; topical
14.4
53.7
92
65
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.2
53.5
608
2983
S71
ICPC
Herpes simplex
10.5
51.4
102
99
S01GX01
ATC
cromoglicic acid; ophthalmic
1.9
51.4
936
5540
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.8
50.1
225
618
N03AX16
ATC
pregabalin; oral
1.8
49.6
989
6026
127
Kela drug reimbursment
Transplant complication
7.6
48.9
118
160
B00.4
ICD-10 Finland
Herpesviral encephalitis
483.1
48.4
48
*
R06AE07
ATC
cetirizine; oral
1.6
48.4
1895
14054
D07AB08
ATC
desonide; topical
2.2
47.8
520
2493
L04AD01
ATC
ciclosporin; systemic
5.9
47.6
137
237
6918B
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]
9.8
47.6
98
102
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
6.7
47.6
125
192
05403
ICD-8 Finland
Herpes simplex, Cutaneus (Eczema herpeticum)
+∞
46.9
45
*
0541B
ICD-9 Finland
Herpes simplex, Genital herpes[HERPES GENITALIS RECIDIVANS]
+∞
46.9
45
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
46.4
438
1959
A02BC02
ATC
pantoprazole; systemic
1.6
45.2
2610
21193
D07AB02
ATC
hydrocortisone butyrate; topical
1.7
45.0
1211
8062
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.9
44.4
775
4488
R03AC02
ATC
salbutamol; inhalant
1.6
43.5
2200
17218
J01FF01
ATC
clindamycin; systemic
1.7
43.3
1118
7338
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
43.1
1507
10752
TAB00
NOMESCO Finland
Lumbar puncture
3.1
42.8
244
806
J01DA01
ATC
[U] cefalexin; systemic
1.6
42.7
2621
21441
L04AA06
ATC
mycophenolic acid; systemic
6.2
41.1
114
189
N02AX02
ATC
tramadol; systemic, rectal
1.6
40.9
1649
12152
H57.1
ICD-10 Finland
Ocular pain
3.6
40.8
191
543
H01.0
ICD-10 Finland
Blepharitis
2.8
40.2
280
1055
B02.8
ICD-10 Finland
Zoster with other complications
25.8
40.2
56
22
A87.9
ICD-10 Finland
Viral meningitis, unspecified
10.6
40.1
79
76
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
40.1
1126
7539
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.2
39.9
461
2260
D07AC13
ATC
mometasone; topical
1.6
39.7
1209
8274
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
39.6
1869
14267
H02AB04
ATC
methylprednisolone; systemic
1.9
39.2
621
3457
H02AB07
ATC
prednisone; oral
1.9
38.8
607
3364
H22.0*B02.3
ICD-10 Finland
Zoster iridocyclitis
+∞
38.6
37
*
05400
ICD-8 Finland
Herpes simplex, Labialis
+∞
38.6
37
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.1
38.1
466
2342
L04AA01
ATC
[U] ciclosporin; systemic
6.0
37.8
107
182
N05BB01
ATC
hydroxyzine; systemic
2.5
37.6
317
1330
0540A
ICD-9 Finland
Herpes simplex, Eczema herpeticum
+∞
37.5
36
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
37.1
2099
16609
R51.80
ICD-10 Finland
Headache
1.9
37.0
651
3757
ZX120
NOMESCO Finland
Intravenous
2.2
36.6
411
1988
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
35.8
807
5041
D07CC01
ATC
betamethasone and antibiotics; topical
1.9
35.4
560
3110
WW500
NOMESCO Finland
Blood transfusion
3.2
35.0
196
640
D70.82
ICD-10 Finland
Drug-induced neutropenia
5.3
35.0
110
213
F29
ICPC
Eye symptom/complaint other
2.2
34.5
362
1697
N02BE01
ATC
paracetamol; systemic, rectal
1.6
34.4
3535
31699
L04AX01
ATC
azathioprine; systemic
2.9
34.1
219
784
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
34.0
836
5351
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.1
34.0
191
625
AA1AD
NOMESCO Finland
CT of head and brain
1.7
34.0
857
5528
XQ800
NOMESCO Finland
Prick test
2.2
34.0
370
1762
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
33.7
687
4153
J02AC01
ATC
fluconazole; systemic
1.5
33.3
1711
13142
F01
ICPC
Eye pain
3.6
33.2
156
446
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.5
32.8
267
1101
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
32.6
543
3066
Z3231
NOMESCO Finland
Registered nurse
1.6
32.3
1080
7500
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
31.7
1204
8615
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
2.4
31.5
288
1261
N03AX12
ATC
gabapentin; oral
1.8
31.3
613
3653
H16.2
ICD-10 Finland
Keratoconjunctivitis
8.6
31.1
68
80
R06AX13
ATC
loratadine; oral
1.7
30.8
671
4131
XW000
NOMESCO Finland
Bone marrow biopsy
3.0
30.7
187
644
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.7
30.3
214
813
N02AA05
ATC
oxycodone; systemic
1.9
30.3
520
2963
D11AX15
ATC
[U] pimecrolimus; topical
17.6
30.1
47
27
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
29.9
330
1579
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
29.9
841
5567
A86
ICD-10 Finland
Unspecified viral encephalitis
12.1
29.6
54
45
J01MA12
ATC
levofloxacin; systemic
1.7
29.5
681
4262
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
29.4
449
2453
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.8
29.2
553
3252
R06.0
ICD-10 Finland
Dyspnoea
1.6
29.2
915
6223
S01FA04
ATC
cyclopentolate; ophthalmic
6.6
29.1
76
117
J01MA02
ATC
ciprofloxacin; systemic
1.5
29.0
1459
11065
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.9
28.8
423
2277
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
2.4
28.7
264
1158
J01FA10
ATC
azithromycin; systemic
1.4
28.6
2388
19988
J01FA06
ATC
roxithromycin; oral
1.5
28.4
1606
12459
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
28.2
356
1803
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
28.2
1781
14117
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.5
27.9
135
396
D02AX
ATC
Other emollients and protectives
2.9
27.6
172
605
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.4
27.5
234
988
A60.0
ICD-10 Finland
Herpesviral infection of genitalia and urogenital tract
4.1
27.3
108
267
H20.1
ICD-10 Finland
Chronic iridocyclitis
6.3
27.0
73
118
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
26.7
519
3074
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.3
26.5
260
1179
J01CA04
ATC
amoxicillin; systemic
1.5
26.4
3337
30014
E000006
ATC
NA
2.1
26.4
314
1551
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
26.3
894
6184
C03CA01
ATC
furosemide; systemic
1.6
26.1
890
6156
J01AA02
ATC
doxycycline; systemic
1.4
26.1
3101
27500
A46
ICD-10 Finland
Erysipelas
1.8
26.1
474
2746
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
2.8
26.0
170
615
J05AB09
ATC
famciclovir; oral
8.3
26.0
58
71
TQW80
NOMESCO Finland
Local dermatologic skincare
3.4
25.9
131
398
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
25.7
1158
8527
ZXD05
NOMESCO Finland
Urgent procedure
1.5
25.5
1198
8898
XQ802
NOMESCO Finland
Epicutan test
2.5
25.4
202
823
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
25.3
681
4435
UJF32
NOMESCO Finland
Coloscopy
1.5
25.3
927
6520
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
25.2
744
4961
R42
ICD-10 Finland
Dizziness and giddiness
1.6
25.1
783
5295
0544B
ICD-9 Finland
Herpes simplex, With ophthalmic complications[KERATITIS DENDRITICA, HERPETICA]
+∞
25.0
24
*
H62.1*B00.19
ICD-10 Finland
Otitis externa in herpesviral [herpes simplex] infection
+∞
25.0
24
*
R06AE09
ATC
levocetirizine; oral
1.7
24.8
594
3743
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
24.8
673
4391
J01MA14
ATC
moxifloxacin; systemic
2.0
24.8
340
1779
B07.9
ICD-10 Finland
Verruca simplex
3.6
24.7
112
313
L03AA02
ATC
filgrastim; parenteral
3.2
24.6
131
414
S01AA01
ATC
chloramphenicol; ophthalmic (antibiotics)
2.3
24.6
242
1099
S01AX11
ATC
[U] ofloxacin; ophthalmic
2.8
24.5
162
591
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.8
24.2
439
2536
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.9
24.2
377
2068
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.9
24.2
408
2301
0549X
ICD-9 Finland
Herpes simplex without mention of complication
+∞
24.0
23
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
23.9
1264
9590
G53.0*B02.20
ICD-10 Finland
Trigeminal neuralgia after shingles
125.7
23.6
25
*
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.9
23.4
361
1972
C01CA24
ATC
epinephrine; parenteral
2.1
23.4
283
1407
A07AA02
ATC
nystatin; oral
2.2
23.3
248
1166
B02
ICD-10 Finland
Zoster [herpes zoster]
2.8
23.2
151
547
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
23.2
795
5488
ZXE00
NOMESCO Finland
One hour or less
1.4
23.1
1517
11975
Z94.0
ICD-10 Finland
Kidney transplant status
5.9
23.0
65
112
A02BC05
ATC
esomeprazole; systemic
1.4
23.0
1523
12038
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
5.0
23.0
74
149
05407
ICD-8 Finland
Herpes simplex, Suspectus
+∞
22.9
22
*
D02AE01
ATC
carbamide; topical
2.0
22.9
288
1454
S01ED01
ATC
timolol; ophthalmic
2.9
22.9
142
497
R06AX27
ATC
desloratadine; oral
1.5
22.8
1102
8200
R01AD09
ATC
mometasone; nasal
1.4
22.8
1794
14616
L20
ICD-10 Finland
Atopic dermatitis
3.0
22.7
132
444
M79.6
ICD-10 Finland
Pain in limb
1.4
22.6
1332
10293
H16.3
ICD-10 Finland
Interstitial and deep keratitis
40.3
22.6
28
7
G05.1
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere
231.1
22.6
23
*
WW200
NOMESCO Finland
Immunization
3.1
22.5
129
429
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.9
22.4
138
483
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.1
22.4
89
222
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
7.8
22.2
51
66
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
22.1
399
2303
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
5.9
21.8
61
104
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.4
21.7
185
782
S01ED51
ATC
timolol, combinations; ophthalmic
2.1
21.7
251
1225
H10
ICD-10 Finland
Conjunctivitis
2.1
21.4
251
1234
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
21.3
279
1434
6BA02
NOMESCO Finland
NA
18.9
21.2
32
17
A02BC01
ATC
omeprazole; systemic
1.5
21.2
1007
7447
H17.1
ICD-10 Finland
Other central corneal opacity
15.6
21.0
34
22
5AB01
NOMESCO Finland
NA
24.3
20.8
29
12
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
20.8
865
6218
E000003
ATC
NA
2.2
20.7
207
946
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.4
20.5
1069
8040
S18
ICPC
Laceration/cut
1.4
20.5
1466
11681
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
20.4
1532
12305
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2.4
20.4
170
711
E000007
ATC
NA
2.1
20.4
250
1251
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.5
20.3
836
5989
P01AB01
ATC
metronidazole; oral, rectal
1.4
20.3
1533
12321
H02AB09
ATC
hydrocortisone; systemic
3.2
20.3
110
354
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
19.9
1383
10955
05406
ICD-8 Finland
Herpes simplex, alius
+∞
19.8
19
*
D11AH02
ATC
pimecrolimus; topical
7.6
19.8
46
61
ZXA10
NOMESCO Finland
Bilateral
1.5
19.8
660
4511
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.9
19.7
125
446
G44.2
ICD-10 Finland
Tension-type headache
1.6
19.7
516
3320
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.5
19.7
159
655
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
7.0
19.6
48
69
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
19.6
474
2986
TGC00
NOMESCO Finland
Bronchial lavation
3.1
19.4
106
343
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.9
19.4
303
1662
Z71.8
ICD-10 Finland
Other specified counselling
1.5
19.3
911
6708
H13.1
ICD-10 Finland
Conjunctivitis in infectious and parasitic diseases classified elsewhere
31.4
19.2
25
8
H18.8
ICD-10 Finland
Other specified disorders of cornea
6.3
19.2
51
82
R03BA05
ATC
fluticasone; inhalant
1.5
19.1
689
4792
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
19.0
549
3621
R03BA02
ATC
budesonide; inhalant
1.5
19.0
668
4620
WX110
NOMESCO Finland
Local anesthesy
1.3
19.0
2712
24013
JN4BD
NOMESCO Finland
Extensive body CT
1.8
18.8
372
2205
Z94.7
ICD-10 Finland
Corneal transplant status
9.6
18.8
38
40
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
3.3
18.8
95
291
M04AA01
ATC
allopurinol; systemic
1.7
18.8
379
2264
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
18.8
602
4075
H10.5
ICD-10 Finland
Blepharoconjunctivitis
3.6
18.7
84
234
ZX108
NOMESCO Finland
Inhalation
6.2
18.7
50
81
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
18.5
1310
10373
D07AD01
ATC
clobetasol; topical
1.6
18.4
561
3748
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.4
18.2
90
271
H17.8
ICD-10 Finland
Other corneal scars and opacities
13.6
18.2
31
23
XCK10
NOMESCO Finland
Photography of fundus of eye
1.8
18.2
342
1996
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
18.1
676
4734
Z3229
NOMESCO Finland
Other healthcare associate professional
1.8
18.0
305
1718
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
2.5
18.0
145
597
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
3.2
17.9
94
297
JN4AD
NOMESCO Finland
Body CT examination
1.9
17.8
258
1378
R03DC03
ATC
montelukast; oral
1.5
17.8
615
4230
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
17.8
450
2865
05409
ICD-8 Finland
Herpes simplex, Unspecified
+∞
17.7
17
*
R01AD08
ATC
fluticasone; nasal
1.4
17.6
1079
8326
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
17.4
320
1854
M54.5
ICD-10 Finland
Low back pain
1.4
17.4
1224
9660
TK800
NOMESCO Finland
Hemodialysis
3.3
17.4
87
265
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
5.9
17.3
48
82
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
3.1
17.3
96
316
CGG45
NOMESCO Finland
Full thickness transplantation of cornea using homograft
13.9
17.2
29
21
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
2.0
17.2
220
1119
G03.9
ICD-10 Finland
Meningitis, unspecified
11.1
17.2
32
29
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
17.1
375
2293
M25.5
ICD-10 Finland
Pain in joint
1.4
17.0
1046
8064
H17.9
ICD-10 Finland
Corneal scar and opacity, unspecified
10.7
16.9
32
30
H53.1
ICD-10 Finland
Subjective visual disturbances
2.0
16.7
227
1185
G02.0
ICD-10 Finland
Meningitis in viral diseases classified elsewhere
+∞
16.7
16
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
16.6
625
4378
T78.4
ICD-10 Finland
Allergy, unspecified
2.1
16.6
200
994
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.7
16.6
383
2377
N05CF01
ATC
zopiclone; oral
1.4
16.6
1105
8631
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
16.5
346
2087
L01.0
ICD-10 Finland
Impetigo [any organism] [any site]
3.7
16.5
72
197
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.9
16.5
259
1426
E000004
ATC
NA
2.9
16.5
102
361
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.2
16.4
85
267
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.8
16.4
310
1813
L03AA13
ATC
pegfilgrastim; parenteral
2.3
16.3
151
668
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.1
16.2
184
893
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
3.7
16.2
71
195
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.8
16.1
301
1752
SPAT1263
SPAT
Sampling
1.3
16.1
1582
13126
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
3.4
16.0
77
228
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
15.7
323
1937
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
4.3
15.5
57
134
R06AX22
ATC
ebastine; oral
1.5
15.5
663
4765
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.6
15.5
110
424
S01EC01
ATC
acetazolamide; systemic
2.9
15.3
91
314
F03
ICPC
Eye discharge
1.9
15.3
237
1296
G53.0
ICD-10 Finland
Postzoster neuralgia
6.7
15.2
38
57
S01GX02
ATC
levocabastine; ophthalmic
1.9
15.2
238
1308
H19.2
ICD-10 Finland
Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere
28.7
15.2
20
7
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
15.1
886
6758
137
Kela drug reimbursment
Uraemia requiring dialysis
5.6
15.1
43
77
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
15.1
417
2714
XQ848
NOMESCO Finland
Dermatological photography
2.8
15.0
99
365
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
15.0
1820
15509
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.8
14.9
96
346
M03BX02
ATC
tizanidine; oral
1.3
14.9
2391
21142
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.6
14.9
67
189
H16.1
ICD-10 Finland
Other superficial keratitis without conjunctivitis
6.5
14.9
38
59
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
14.9
941
7268
S87
ICPC
Dermatitis/atopic eczema
2.7
14.8
100
372
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
14.8
820
6183
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
7.0
14.8
36
52
WX002
NOMESCO Finland
Sedation and analgesia
1.4
14.8
658
4762
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
16.5
14.7
23
14
CG2S4
NOMESCO Finland
Photography of cornea
8.3
14.7
32
39
B01.9
ICD-10 Finland
Varicella without complication
18.4
14.7
22
12
J01FA09
ATC
clarithromycin; systemic
1.3
14.7
1173
9401
WZC30
NOMESCO Finland
Teaching
1.6
14.6
450
3005
TCG10
NOMESCO Finland
Removal of sutures from cornea
7.4
14.6
34
46
R74
ICPC
Upper respiratory infection acute
1.3
14.6
1094
8677
B00.7
ICD-10 Finland
Disseminated herpesviral disease
+∞
14.6
14
*
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.7
14.6
280
1646
ZXA00
NOMESCO Finland
Right side
1.4
14.5
899
6914
Z2446
NOMESCO Finland
Social worker
1.8
14.4
234
1302
C07AB07
ATC
bisoprolol; oral
1.3
14.4
1497
12461
B00
ICD-10 Finland
Herpesviral [herpes simplex] infections
10.1
14.4
28
28
D70.89
ICD-10 Finland
Neutropenic splenomegaly
3.8
14.4
60
159
R03BA01
ATC
beclometasone; inhalant
1.5
14.4
506
3485
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.9
14.4
210
1126
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
12.6
14.3
25
20
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
14.3
832
6325
SPAT1153
SPAT
Removal of sutures
1.3
14.3
1076
8533
R01AD01
ATC
beclometasone; nasal
1.5
14.2
567
4010
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.1
14.2
167
824
R01AD12
ATC
fluticasone furoate; nasal
1.3
14.2
1130
9044
R02
ICPC
Shortness of breath/dyspnoea
1.6
14.2
394
2569
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.7
14.1
290
1741
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.7
14.1
290
1742
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
42.6
14.1
17
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.8
14.1
235
1322
A03
ICPC
Fever
1.5
14.0
582
4154
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
14.0
979
7672
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.8
14.0
243
1384
B05DA
ATC
Isotonic solutions
6.6
14.0
35
53
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.9
14.0
45
93
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.8
13.9
222
1230
P01BA02
ATC
hydroxychloroquine; oral
1.7
13.9
296
1795
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.1
13.9
75
244
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.8
13.8
57
150
N05BA04
ATC
oxazepam; oral
1.4
13.8
888
6867
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.8
13.8
226
1261
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
13.7
319
1982
R52.9
ICD-10 Finland
Pain, unspecified
1.7
13.7
291
1762
A11CC03
ATC
alfacalcidol; systemic
2.9
13.7
84
294
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
13.7
641
4680
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.0
13.7
170
858
R53
ICD-10 Finland
Malaise and fatigue
1.4
13.7
710
5286
B01AB05
ATC
enoxaparin; parenteral
1.3
13.7
1010
7982
L51.9
ICD-10 Finland
Erythema multiforme, unspecified
9.1
13.7
28
31
XX3DW
NOMESCO Finland
Time consuming IT work
1.6
13.7
333
2097
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
6.9
13.6
33
48
M79.1
ICD-10 Finland
Myalgia
1.5
13.6
457
3118
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
13.5
372
2415
B00.3
ICD-10 Finland
Herpesviral meningitis
+∞
13.5
13
*
H13.1*B02.3
ICD-10 Finland
Zoster conjunctivitis
+∞
13.5
13
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.0
13.5
177
912
D07BC01
ATC
betamethasone and antiseptics; topical
1.5
13.5
421
2820
A01
ICPC
Pain general/multiple sites
1.7
13.5
265
1571
CG2T4
NOMESCO Finland
Topography assessment of cornea
4.7
13.5
45
97
A12AA04
ATC
calcium carbonate; oral
3.6
13.4
60
169
TCG00
NOMESCO Finland
Protection of cornea and sclera with soft lens
9.4
13.4
27
29
H16.8
ICD-10 Finland
Other keratitis
9.4
13.4
27
29
R60.0
ICD-10 Finland
Localized oedema
1.6
13.4
344
2195
H26.2
ICD-10 Finland
Complicated cataract
3.7
13.3
57
155
F73
ICPC
Eye infection/inflammation other
2.8
13.3
87
319
N03AF01
ATC
carbamazepine; oral, rectal
2.0
13.3
179
931
R03AC03
ATC
terbutaline; inhalant
1.5
13.3
518
3649
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
13.2
527
3726
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
2.7
13.2
90
337
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
13.2
573
4124
S29
ICPC
Skin symptom/complaint other
1.5
13.2
562
4028
C08CA01
ATC
amlodipine; oral
1.3
13.1
1063
8510
R4110
NOMESCO Finland
Physiotherapy
1.4
13.1
898
7011
H15.1
ICD-10 Finland
Episcleritis
3.1
12.9
71
234
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.8
12.9
235
1358
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.7
12.9
258
1539
H02AB02
ATC
dexamethasone; systemic
1.6
12.8
341
2198
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.5
12.8
463
3205
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
12.7
1131
9171
A04AA02
ATC
granisetron; systemic, transdermal
1.8
12.7
208
1163
D06BX01
ATC
metronidazole; topical
1.6
12.6
380
2522
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.7
12.6
85
320
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.5
12.6
441
3031
R11
ICD-10 Finland
Nausea and vomiting
1.7
12.6
277
1697
B94.1
ICD-10 Finland
Sequelae of viral encephalitis
70.1
12.6
14
*
H26.3
ICD-10 Finland
Drug-induced cataract
6.4
12.6
32
50
N06AX11
ATC
mirtazapine; oral
1.3
12.6
1129
9166
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
4.4
12.6
44
100
A41.9
ICD-10 Finland
Sepsis, unspecified
2.3
12.5
118
529
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
12.5
2740
24920
L01.1
ICD-10 Finland
Impetiginization of other dermatoses
5.5
12.5
36
66
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
17.3
12.5
19
11
B03XA02
ATC
darbepoetin alfa; parenteral
3.0
12.5
69
229
N06AB10
ATC
escitalopram; oral
1.4
12.5
742
5653
B05DB
ATC
Hypertonic solutions
7.3
12.4
29
40
H22.0
ICD-10 Finland
Iridocyclitis in infectious and parasitic diseases classified elsewhere
130.4
12.4
13
*
R05
ICPC
Cough
1.4
12.4
791
6091
H26.4
ICD-10 Finland
After-cataract
1.7
12.4
253
1515
XA800
NOMESCO Finland
Neuropsychological investigation
2.1
12.4
144
708
K12.10
ICD-10 Finland
Stomatitis NOS
6.0
12.4
33
55
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
12.4
343
2235
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
12.3
812
6289
H18.1
ICD-10 Finland
Bullous keratopathy
11.6
12.3
22
19
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.8
12.3
231
1349
JN3AD
NOMESCO Finland
Abdominal CT examination
1.7
12.2
243
1442
120
Kela drug reimbursment
Hypogammaglobulinaemia
14.3
12.2
20
14
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
8.4
12.2
26
31
ZXA05
NOMESCO Finland
Left side
1.4
12.2
816
6335
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.1
12.1
135
650
Z3226
NOMESCO Finland
Physiotherapist
1.4
12.1
631
4690
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
12.1
469
3295
S70
ICPC
Herpes zoster
2.7
12.1
82
310
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.0
12.1
67
223
S01XA18
ATC
ciclosporin; ophthalmic
5.4
12.0
35
65
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
12.0
2053
18077
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.5
12.0
89
354
F02
ICPC
Red eye
2.0
12.0
148
745
R05
ICD-10 Finland
Cough
1.4
12.0
664
4993
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.8
12.0
194
1081
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
10.0
12.0
23
23
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.7
11.9
239
1426
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.0
11.9
154
793
S01EA03
ATC
apraclonidine; ophthalmic
4.4
11.8
42
97
B03XA01
ATC
erythropoietin; parenteral
4.6
11.8
40
88
A04AA01
ATC
ondansetron; systemic, rectal
1.7
11.7
221
1294
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.0
11.7
154
796
H53.2
ICD-10 Finland
Diplopia
2.4
11.7
99
423
K50.8
ICD-10 Finland
Other Crohn disease
3.0
11.6
65
218
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.0
11.6
141
707
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
11.6
460
3243
WW300
NOMESCO Finland
Transfer of autologic stem cells
6.0
11.6
31
52
D11
ICPC
Diarrhoea
1.5
11.6
392
2674
A87.8
ICD-10 Finland
Other viral meningitis
65.1
11.6
13
*
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
2.4
11.6
100
429
K02.1
ICD-10 Finland
Caries of dentine
1.2
11.5
2155
19138
H66.9
ICD-10 Finland
Otitis media, unspecified
1.8
11.5
205
1177
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
11.5
314
2037
A01AB09
ATC
miconazole; local oral
1.6
11.5
300
1924
D07AB01
ATC
clobetasone; topical
2.1
11.5
122
579
0544C
ICD-9 Finland
Herpes simplex, With ophthalmic complications[KERATITIS DISCIFORMIS, HERPETICA]
+∞
11.5
11
*
0543B
ICD-9 Finland
Herpes simplex, Herpetic meningoencephalitis[ENCEPHALITIS HERPETICA]
+∞
11.5
11
*
0544A
ICD-9 Finland
Herpes simplex, With ophthalmic complications[HERPES SIMPLEX PALPEBRAE OCULI]
+∞
11.5
11
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
11.4
504
3634
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
11.4
854
6741
SPAT1254
SPAT
Administration of medicine
1.5
11.4
473
3370
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
4.4
11.4
40
92
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
11.3
400
2753
S01EE01
ATC
latanoprost; ophthalmic
1.8
11.3
177
975
J01EA01
ATC
trimethoprim; systemic
1.3
11.3
911
7270
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
2.1
11.2
131
647
N06AA09
ATC
amitriptyline; systemic
1.6
11.2
336
2228
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
11.2
1356
11422
Z51.5
ICD-10 Finland
Palliative care
1.9
11.2
168
911
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
2.9
11.2
67
236
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.5
11.1
379
2590
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
11.1
978
7897
134
Kela drug reimbursment
General erythroderma
6.4
11.1
28
44
SPAT1255
SPAT
Intravenous administration of medicine
1.8
11.0
204
1185
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.9
11.0
165
894
N06AX16
ATC
venlafaxine; oral
1.4
11.0
496
3590
M13.9
ICD-10 Finland
Arthritis, unspecified
1.7
11.0
236
1435
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.5
11.0
424
2977
A06AD11
ATC
lactulose; oral
1.5
11.0
428
3008
Z2221
NOMESCO Finland
Medical doctor
1.3
10.9
1000
8120
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
4.4
10.9
38
87
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.3
10.9
94
407
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.7
10.9
235
1432
J45
ICD-10 Finland
Asthma
1.5
10.9
332
2211
M01AE02
ATC
naproxen; oral, rectal
1.2
10.9
2148
19146
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.6
10.9
277
1766
N77.1*A60.0
ICD-10 Finland
Vaginitis, vulvitis and vulvovaginitis in herpesviral [herpes simplex] infection
5.7
10.8
30
53
N01
ICPC
Headache
1.5
10.8
370
2531
L08.0
ICD-10 Finland
Pyoderma
3.7
10.8
46
126
H01
ICPC
Ear pain/earache
1.5
10.8
372
2549
R21
ICPC
Throat symptom/complaint
1.3
10.8
716
5544
A41.8
ICD-10 Finland
Other specified sepsis
3.0
10.6
59
198
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.8
10.6
181
1029
N30.0
ICD-10 Finland
Acute cystitis
1.4
10.6
473
3416
R03BB04
ATC
tiotropium bromide; inhalant
1.6
10.6
284
1834
N05CF02
ATC
zolpidem; oral
1.4
10.6
614
4648
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
6.3
10.6
27
43
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.3
10.6
742
5792
M01AB05
ATC
diclofenac; systemic, rectal
1.2
10.5
2497
22675
M05BA04
ATC
alendronic acid; oral
1.6
10.5
242
1503
H02.4
ICD-10 Finland
Ptosis of eyelid
2.4
10.5
88
374
R03AC13
ATC
formoterol; inhalant
1.8
10.5
163
897
CG2X4
NOMESCO Finland
Optical coherence tomography (OCT) of cornea
4.8
10.5
34
72
A02BC03
ATC
lansoprazole; oral
1.3
10.5
980
7967
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
10.5
1428
12178
J45.1
ICD-10 Finland
Nonallergic asthma
1.7
10.5
230
1410
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.7
10.5
223
1353
A02BA02
ATC
ranitidine; systemic
1.4
10.4
638
4870
05699
ICD-8 Finland
Rubella, Non definita
+∞
10.4
10
*
B005H
ICD-10 Finland
NA
+∞
10.4
10
*
B02.0
ICD-10 Finland
Zoster encephalitis
+∞
10.4
10
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
4.2
10.4
38
91
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.9
10.4
144
761
N18.8
ICD-10 Finland
Other chronic renal failure
2.4
10.3
84
353
L50.9
ICD-10 Finland
Urticaria, unspecified
2.0
10.3
126
633
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.8
10.3
161
888
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
1.9
10.3
141
742
L57.0
ICD-10 Finland
Actinic keratosis
1.6
10.3
263
1679
A07EA06
ATC
budesonide; oral, local oral
2.1
10.2
119
587
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
2.5
10.2
76
303
UKC02
NOMESCO Finland
Cystoscopy
1.4
10.2
454
3274
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.1
10.2
107
505
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
4.3
10.2
36
84
N06AX21
ATC
duloxetine; oral
1.5
10.2
380
2647
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.7
10.1
231
1429
H00.03
ICD-10 Finland
Preseptal cellulite in the eyelid
6.2
10.1
26
42
H01.80
ICD-10 Finland
Prolonged inflammation in the edge of the eyelid
4.2
10.1
37
89
D06BB06
ATC
penciclovir; topical
5.2
10.1
30
58
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.7
10.1
229
1416
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.9
10.1
59
205
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.7
10.0
227
1404
J01CF05
ATC
flucloxacillin; systemic
2.0
10.0
120
601
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.2
10.0
103
482
114
Kela drug reimbursment
Glaucoma
1.6
10.0
238
1489
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
10.0
10.0
19
19
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.9
10.0
133
695
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
10.0
117
579
H03AA01
ATC
levothyroxine sodium; systemic
1.3
10.0
811
6462
K12.00
ICD-10 Finland
Recurrent oral aphthae
3.0
10.0
57
193
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
9.9
804
6404
Z49.0
ICD-10 Finland
Preparatory care for dialysis
4.0
9.9
38
96
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
9.9
392
2766
395
Kela drug reimbursment
Dupilumab
16.7
9.9
15
9
R51.81
ICD-10 Finland
Facial pain NOS
2.3
9.8
86
373
S22.3
ICD-10 Finland
Fracture of rib
1.7
9.8
197
1178
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
12.2
9.8
17
14
L17
ICPC
Foot/toe symptom/complaint
1.3
9.8
829
6639
1XC02
NOMESCO Finland
NA
4.2
9.8
36
87
WX290
NOMESCO Finland
Other blockade of nerve
1.2
9.8
1638
14273
SBB10
NOMESCO Finland
Teeth copy
1.7
9.8
215
1318
WX892
NOMESCO Finland
Monitored bed care
1.6
9.8
233
1460
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
9.8
233
1462
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
3.2
9.8
49
154
N06AB04
ATC
citalopram; systemic
1.3
9.8
740
5839
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.5
9.7
315
2129
H18.6
ICD-10 Finland
Keratoconus
4.5
9.7
33
74
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
4.5
9.7
33
74
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.9
9.7
56
192
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.1
9.7
111
547
N03AE01
ATC
clonazepam; systemic
1.7
9.7
195
1165
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
3.6
9.7
42
118
NF1AA
NOMESCO Finland
Hip X-ray examination
1.6
9.7
244
1552
CGF35
NOMESCO Finland
Repair of cornea using graft
55.1
9.6
11
*
L30.3
ICD-10 Finland
Infective dermatitis
2.0
9.6
115
576
X58
ICD-10 Finland
Exposure to other specified factors
1.4
9.6
454
3310
S01GX09
ATC
olopatadine; ophthalmic
2.2
9.6
98
458
XCK00
NOMESCO Finland
Perimetry
1.7
9.6
211
1292
K59.09
ICD-10 Finland
Constipation, unspecified
1.7
9.6
180
1054
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
9.5
1414
12147
A07EC01
ATC
sulfasalazine; oral, rectal
1.6
9.5
272
1783
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.7
9.5
176
1025
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
9.5
2138
19206
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
5.2
9.5
28
54
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
9.5
1293
11000
H10.4
ICD-10 Finland
Chronic conjunctivitis
3.6
9.5
41
115
R20.2
ICD-10 Finland
Paraesthesia of skin
1.6
9.4
227
1429
XCH00
NOMESCO Finland
Eye pressure measurement
1.9
9.4
124
647
H62.1*B02.8
ICD-10 Finland
Otitis externa in zoster
+∞
9.4
9
*
G05.1*B02.0
ICD-10 Finland
Zoster encephalitis
+∞
9.4
9
*
H190, B005
ICD-10 Finland
NA
+∞
9.4
9
*
J20
ICD-10 Finland
Acute bronchitis
1.5
9.4
315
2148
JN6AD
NOMESCO Finland
CT of torso and neck
3.1
9.3
48
154
N77.0*A60.0
ICD-10 Finland
Ulceration of vulva in herpesviral [herpes simplex] infection
6.9
9.3
22
32
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.8
9.2
165
955
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.7
9.2
182
1084
SPAT1301
SPAT
No procedures
1.3
9.2
1064
8874
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
3.3
9.2
44
134
S01BA07
ATC
fluorometholone; ophthalmic (corticosteroids, plain)
2.6
9.2
64
249
D07AC14
ATC
methylprednisolone aceponate; topical
1.8
9.2
164
947
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
9.1
1071
8946
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.6
9.1
264
1739
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.4
9.1
500
3750
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.8
9.0
154
877
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
5.9
9.0
24
41
R03AK08
ATC
formoterol and beclometasone; inhalant
1.9
9.0
127
678
A05AA02
ATC
ursodeoxycholic acid; oral
2.5
9.0
69
282
TCF00
NOMESCO Finland
Subconjunctival therapeutic injection
10.0
9.0
17
17
Z49.2
ICD-10 Finland
Other dialysis
4.7
9.0
29
62
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.6
9.0
254
1662
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
3.6
9.0
38
105
K59.0
ICD-10 Finland
Constipation
1.7
9.0
168
986
49300
ICD-8 Finland
Asthma, bronchiale
2.3
8.9
81
361
R07.3
ICD-10 Finland
Other chest pain
1.5
8.9
286
1929
Z2445
NOMESCO Finland
Psychologist
1.9
8.9
132
718
K59.1
ICD-10 Finland
Functional diarrhoea
1.8
8.9
160
927
L27.2
ICD-10 Finland
Dermatitis due to ingested food
3.7
8.9
37
101
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.6
8.8
237
1534
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.5
8.8
285
1925
G47.3
ICD-10 Finland
Sleep apnoea
1.3
8.8
641
5020
GD1AD
NOMESCO Finland
Thorax CT examination
1.9
8.8
121
640
ZXE20
NOMESCO Finland
More than three and less than five hours
1.4
8.8
428
3141
L50.8
ICD-10 Finland
Other urticaria
2.5
8.8
67
272
K50.9
ICD-10 Finland
Crohn disease, unspecified
2.7
8.8
56
206
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
8.6
8.8
18
21
K30
ICD-10 Finland
Functional dyspepsia
1.5
8.8
332
2322
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.3
8.8
890
7294
R05FB02
ATC
cough suppressants and expectorants
1.2
8.8
1278
10935
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
6.3
8.8
22
35
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
8.7
1775
15728
R55
ICD-10 Finland
Syncope and collapse
1.5
8.7
320
2220
C83.1
ICD-10 Finland
Mantle cell lymphoma
5.9
8.7
23
39
Z00.0
ICD-10 Finland
General medical examination
1.3
8.7
611
4756
R07.0
ICD-10 Finland
Pain in throat
1.6
8.7
207
1297
A10AE04
ATC
insulin glargine; parenteral
1.5
8.7
272
1826
L04AA05
ATC
[U] tacrolimus; systemic
14.0
8.7
14
10
L71.8
ICD-10 Finland
Other rosacea
2.7
8.7
57
215
G43.9
ICD-10 Finland
Migraine, unspecified
1.6
8.7
205
1284
WF049
NOMESCO Finland
Radiotherapy of metastasis
2.1
8.7
89
420
L88
ICPC
Rheumatoid/seropositive arthritis
1.9
8.6
124
667
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
8.6
1403
12145
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
7.6
8.6
19
25
G50.1
ICD-10 Finland
Atypical facial pain
2.5
8.6
66
269
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
8.6
978
8127
N05AH04
ATC
quetiapine; oral
1.3
8.6
549
4215
G50.0
ICD-10 Finland
Trigeminal neuralgia
2.5
8.6
63
252
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.4
8.6
477
3579
S21
ICPC
Skin texture symptom/complaint
1.4
8.6
379
2734
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.4
8.5
350
2486
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
3.0
8.5
47
159
SPAT1260
SPAT
Consultation of another employee
1.3
8.5
589
4577
M54.2
ICD-10 Finland
Cervicalgia
1.6
8.5
229
1485
K50.1
ICD-10 Finland
Crohn disease of large intestine
2.8
8.5
51
182
D07XC01
ATC
betamethasone, combinations; topical
1.4
8.5
374
2693
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
3.7
8.5
35
95
H10.2
ICD-10 Finland
Other acute conjunctivitis
2.9
8.5
49
169
S01FA02
ATC
scopolamine; ophthalmic
3.3
8.5
40
121
S01GX05
ATC
lodoxamide; ophthalmic
2.9
8.5
50
176
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
2.2
8.5
85
397
CD2S4
NOMESCO Finland
Photography of eye
4.5
8.5
28
62
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
5.1
8.4
25
49
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
2.8
8.4
51
183
R52.2
ICD-10 Finland
Other chronic pain
1.9
8.4
114
601
C02AC05
ATC
moxonidine; oral
1.9
8.4
122
660
L03.2
ICD-10 Finland
Cellulitis of face
3.8
8.4
34
91
R96
ICPC
Asthma
1.5
8.4
280
1909
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
8.4
985
8218
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
3.4
8.4
39
117
ZX112
NOMESCO Finland
Subcutaneous
2.2
8.4
79
358
37100
ICD-8 Finland
Corneal opacity, Cicatrix (nubecula, macula, leucoma) cornea
+∞
8.3
8
*
05209
ICD-8 Finland
Chickenpox, Unspecified
+∞
8.3
8
*
H192, B005
ICD-10 Finland
NA
+∞
8.3
8
*
R06AX26
ATC
fexofenadine; oral
1.6
8.3
230
1500
W19
ICD-10 Finland
Unspecified fall
1.5
8.3
285
1952
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.2
8.3
79
360
TQW99
NOMESCO Finland
Other minor procedure on skin
1.8
8.3
142
810
M05BX04
ATC
denosumab; parenteral
1.8
8.3
136
765
N05BA01
ATC
diazepam; systemic, rectal
1.4
8.3
426
3158
CKD15
NOMESCO Finland
Injection of vitreous substitute
5.2
8.3
24
46
J01.1
ICD-10 Finland
Acute frontal sinusitis
2.6
8.3
57
220
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
3.4
8.3
38
113
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.5
8.2
269
1822
S01EC04
ATC
brinzolamide; ophthalmic
2.0
8.2
104
535
M54.3
ICD-10 Finland
Sciatica
1.6
8.2
186
1154
K08.80
ICD-10 Finland
Toothache NOS
1.5
8.2
270
1835
SPAT1312
SPAT
General health counselling
1.2
8.2
1124
9541
L71.9
ICD-10 Finland
Rosacea, unspecified
2.2
8.1
76
345
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
5.1
8.1
24
47
J01FA01
ATC
erythromycin; systemic
1.3
8.1
502
3833
J02AC02
ATC
itraconazole; systemic
1.3
8.1
613
4824
S01FA01
ATC
atropine; ophthalmic
4.7
8.1
26
56
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
2.3
8.1
72
319
UDC00
NOMESCO Finland
Ear microscopy
1.6
8.1
224
1462
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
8.1
8.1
17
21
ZYC01
NOMESCO Finland
Remote contact by phone
1.7
8.0
152
896
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
10.0
8.0
15
15
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.4
8.0
405
2993
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
8.0
1954
17576
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
2.1
8.0
89
436
C05AA08
ATC
fluocortolone; rectal, topical
1.4
8.0
463
3500
R51
ICD-10 Finland
Headache
1.7
8.0
175
1076
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
2.7
8.0
51
189
D09AB01
ATC
zinc bandage without supplements; topical
2.3
7.9
68
295
WW409
NOMESCO Finland
Other aferesis
7.2
7.9
18
25
R02AD02
ATC
lidocaine; local oral
2.2
7.9
79
369
Z01.9
ICD-10 Finland
Special examination, unspecified
1.7
7.9
168
1024
C07AB02
ATC
metoprolol; systemic
1.3
7.9
590
4634
Z01.2
ICD-10 Finland
Dental examination
1.2
7.9
1461
12791
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.0
7.9
95
480
A92
ICPC
Allergy/allergic reaction NOS
2.0
7.9
93
468
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
7.8
244
1640
B34.9
ICD-10 Finland
Viral infection, unspecified
2.0
7.8
97
497
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.8
7.8
132
751
F70
ICPC
Conjunctivitis infectious
2.1
7.8
80
377
ZY010
NOMESCO Finland
Hospital outpatient
1.7
7.8
162
983
J01AA04
ATC
lymecycline; systemic
1.4
7.8
455
3445
A63.0
ICD-10 Finland
Anogenital (venereal) warts
1.8
7.8
128
723
H01.9
ICD-10 Finland
Inflammation of eyelid, unspecified
2.9
7.8
43
147
L04AA13
ATC
leflunomide; oral
2.0
7.8
89
439
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
7.7
490
3758
N18.0
ICD-10 Finland
End-stage renal disease
3.0
7.7
41
136
K12.18
ICD-10 Finland
Other forms of stomatitis
3.6
7.7
33
93
R03AK07
ATC
formoterol and budesonide; inhalant
1.3
7.7
634
5048
G50.8
ICD-10 Finland
Other disorders of trigeminal nerve
7.4
7.7
17
23
ED1AA
NOMESCO Finland
Mandipular X-ray examination
3.9
7.6
29
74
SPAT1216
SPAT
Assessment of functional ability
1.4
7.6
425
3192
-1
NOMESCO Finland
NA
1.2
7.6
1190
10233
L01
ICPC
Neck symptom/complaint
1.4
7.6
435
3284
WX402
NOMESCO Finland
General anaesthesia
1.3
7.5
532
4146
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.5
7.5
221
1462
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.3
7.5
63
272
YNB10
NOMESCO Finland
Collection of stem cells for transplant
8.8
7.5
15
17
V03AE01
ATC
polystyrene sulfonate; oral
3.0
7.5
41
139
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.7
7.5
164
1007
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.2
7.5
920
7699
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
2.6
7.5
50
192
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.6
7.5
164
1011
J46
ICD-10 Finland
Status asthmaticus
2.0
7.5
92
470
H33.0
ICD-10 Finland
Retinal detachment with retinal break
2.1
7.5
83
407
D20
ICPC
Mouth/tongue/lip symptom/complaint
1.8
7.4
131
758
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.3
7.4
728
5931
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.9
7.4
98
515
R03BA08
ATC
ciclesonide; inhalant
1.5
7.4
269
1866
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
7.4
2645
24575
ZX121
NOMESCO Finland
Central venous catheter
5.3
7.4
21
40
L01
ICD-10 Finland
Impetigo
2.7
7.4
48
181
G01AF05
ATC
econazole; vaginal
1.5
7.4
269
1871
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.6
7.4
169
1052
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
5.6
7.4
20
36
H00.1
ICD-10 Finland
Chalazion
1.8
7.3
111
612
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
2.9
7.3
42
145
L23.9
ICD-10 Finland
Allergic contact dermatitis, unspecified cause
3.1
7.3
38
125
05710
ICD-8 Finland
Other viral exanthem, Exanthema subitum (sixth disease)
+∞
7.3
7
*
0548X
ICD-9 Finland
Herpes simplex, With unspecified complication
+∞
7.3
7
*
D07CB01
ATC
triamcinolone and antibiotics; topical
2.1
7.3
74
348
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.6
7.3
173
1087
L51.8
ICD-10 Finland
Other erythema multiforme
9.4
7.3
14
15
M03BX01
ATC
baclofen; systemic
2.3
7.3
61
264
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
4.9
7.3
22
45
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.1
7.3
81
397
I50.9
ICD-10 Finland
Heart failure, unspecified
1.4
7.2
309
2215
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
6.2
7.2
18
29
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
6.2
7.2
18
29
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.6
7.2
166
1036
C90.0
ICD-10 Finland
Multiple myeloma
3.4
7.2
33
99
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.6
7.2
50
194
H25.8
ICD-10 Finland
Other senile cataract
1.5
7.2
255
1762
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
1.9
7.2
96
507
WZA90
NOMESCO Finland
Other doctors statement
1.3
7.2
756
6216
J30.3
ICD-10 Finland
Other allergic rhinitis
1.8
7.1
121
692
L28
ICPC
Limited function/disability (L)
1.3
7.1
431
3280
C10AA05
ATC
atorvastatin; oral
1.2
7.1
1066
9108
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
30.0
7.1
9
*
A10AE05
ATC
insulin detemir; parenteral
1.6
7.1
162
1007
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.4
7.1
58
248
H17.0
ICD-10 Finland
Adherent leukoma
20.0
7.1
10
5
B02.20
ICD-10 Finland
Herpes zoster trigeminal neuralgia
20.0
7.1
10
5
D11AH05
ATC
dupilumab; topical
20.0
7.1
10
5
H16.4
ICD-10 Finland
Corneal neovascularization
20.0
7.1
10
5
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
20.0
7.1
10
5
N05CD08
ATC
midazolam; nasal, systemic
2.3
7.1
63
280
G04CA02
ATC
tamsulosin; oral
1.3
7.1
511
3989
EBA10
NOMESCO Finland
Surgical removal of tooth
1.4
7.1
390
2920
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
7.9
7.1
15
19
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
1.8
7.1
122
700
S06.0
ICD-10 Finland
Concussion
1.4
7.1
318
2298
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
4.2
7.1
25
60
F45.8
ICD-10 Finland
Other somatoform disorders
1.5
7.1
241
1652
D01
ICPC
Abdominal pain/cramps general
1.4
7.1
338
2472
R01AD05
ATC
budesonide; nasal
1.5
7.1
255
1767
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
1.5
7.1
272
1911
TK820
NOMESCO Finland
Peritoneal dialysis
5.6
7.0
19
34
B01AB10
ATC
tinzaparin; parenteral
1.5
7.0
202
1332
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
2.8
7.0
42
151
H18.5
ICD-10 Finland
Hereditary corneal dystrophies
3.3
7.0
33
101
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.0
7.0
86
438
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
2.0
7.0
88
452
H92.0
ICD-10 Finland
Otalgia
1.6
7.0
161
1006
J01AA07
ATC
tetracycline; systemic
1.3
7.0
524
4116
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
3.2
7.0
34
107
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
7.0
7.0
16
23
J31.0
ICD-10 Finland
Chronic rhinitis
1.5
7.0
248
1713
S01AA02
ATC
chlortetracycline; ophthalmic
3.5
7.0
30
86
R78
ICPC
Acute bronchitis/bronchiolitis
2.2
6.9
67
310
D07XB05
ATC
dexamethasone, combinations; topical
1.9
6.9
88
457
A07AA09
ATC
vancomycin; oral
2.8
6.9
42
153
A07EC02
ATC
mesalazine; oral, rectal
1.6
6.9
171
1087
M01CB01
ATC
sodium aurothiomalate; parenteral
2.5
6.9
52
212
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
13.8
6.9
11
8
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.3
6.9
584
4669
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
1.8
6.9
118
676
T74.1
ICD-10 Finland
Physical abuse
2.2
6.9
66
304
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
1.4
6.8
347
2567
J47
ICD-10 Finland
Bronchiectasis
2.4
6.8
53
222
R60.9
ICD-10 Finland
Oedema, unspecified
1.7
6.8
137
822
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
6.8
624
5034
Y84.9
ICD-10 Finland
Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.4
6.8
23
53
N30
ICD-10 Finland
Cystitis
1.5
6.8
245
1699
Z00.8
ICD-10 Finland
Other general examinations
1.5
6.8
214
1441
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
2.1
6.8
69
328
R4120
NOMESCO Finland
Occupational therapy
1.5
6.8
196
1295
M31.7
ICD-10 Finland
Microscopic polyangiitis
10.9
6.8
12
11
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
9.3
6.8
13
14
69519
ICD-8 Finland
Erythematous condition, Erythema multiforme NUD
40.1
6.8
8
*
S83.2
ICD-10 Finland
Tear of meniscus, current
1.5
6.7
209
1403
WXQ24
NOMESCO Finland
UVB/UVA light therapy
16.7
6.7
10
6
36399
ICD-8 Finland
Keratitis, Without mention of ulcer
16.7
6.7
10
6
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.6
6.7
153
952
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
2.3
6.7
60
268
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.2
6.7
1364
12008
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
6.7
394
2985
A06AC51
ATC
ispaghula, combinations; systemic
1.6
6.7
149
921
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
6.7
527
4173
ZX131
NOMESCO Finland
Intrathecal
22.5
6.7
9
*
J01MA01
ATC
ofloxacin; systemic
1.5
6.7
243
1691
SPAT1262
SPAT
Handing over of treatment supplies
1.3
6.6
524
4148
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.7
6.6
132
793
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
2.9
6.6
38
132
Z94.2
ICD-10 Finland
Lung transplant status
7.8
6.6
14
18
C10AC01
ATC
colestyramine; oral
2.0
6.6
83
429
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
1.6
6.6
142
873
D69.5
ICD-10 Finland
Secondary thrombocytopenia
5.5
6.6
18
33
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
2.4
6.6
53
224
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
2.0
6.6
76
379
SPAT1310
SPAT
Counselling related to known health issue
1.2
6.6
1083
9338
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.5
6.6
207
1395
CFD10
NOMESCO Finland
Repair of conjunctiva
12.2
6.6
11
9
M02AA07
ATC
piroxicam; topical
1.2
6.6
1197
10421
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.1
6.6
72
354
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.1
6.6
72
354
S01BC05
ATC
ketorolac; ophthalmic
1.8
6.6
108
612
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
6.5
602
4859
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
8.7
6.5
13
15
B01AF02
ATC
apixaban; oral
1.5
6.5
240
1672
N30.9
ICD-10 Finland
Cystitis, unspecified
1.6
6.5
167
1075
ZXC50
NOMESCO Finland
Cryotherapy
2.0
6.5
74
369
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.5
6.5
187
1237
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
6.5
364
2735
L73.8
ICD-10 Finland
Other specified follicular disorders
3.0
6.5
35
119
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
2.5
6.5
46
182
S76
ICPC
Skin infection other
1.6
6.5
141
870
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
1.9
6.5
92
496
N05CD07
ATC
temazepam; oral
1.4
6.5
344
2564
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
1.8
6.5
109
621
U02
ICPC
Urinary frequency/urgency
1.3
6.5
406
3106
A28
ICPC
Limited function/disability NOS
1.3
6.5
379
2872
H40.0
ICD-10 Finland
Glaucoma suspect
1.5
6.5
210
1426
D06BB04
ATC
podophyllotoxin; topical
1.6
6.4
171
1110
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.8
6.4
94
514
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
2.9
6.4
35
120
B02.7
ICD-10 Finland
Disseminated zoster
69.9
6.4
7
*
M79.7
ICD-10 Finland
Fibromyalgia
1.7
6.4
116
678
V03AE02
ATC
sevelamer; oral
4.2
6.4
22
52
CGG99
NOMESCO Finland
Other reconstructive operations on cornea and sclera
14.3
6.4
10
7
L51.1
ICD-10 Finland
Bullous erythema multiforme
14.3
6.4
10
7
L30.0
ICD-10 Finland
Nummular dermatitis
1.8
6.4
99
550
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
2.9
6.4
37
130
R04.0
ICD-10 Finland
Epistaxis
1.5
6.4
184
1218
J01DA06
ATC
[U] cefuroxime; systemic
1.3
6.4
475
3730
-59
ICPC
Other therap proced/minor surg NEC
1.9
6.4
85
448
N03AG01
ATC
valproic acid; systemic, rectal
1.5
6.4
194
1298
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
1.7
6.4
136
834
K11.2
ICD-10 Finland
Sialoadenitis
1.8
6.3
97
538
S20.2
ICD-10 Finland
Contusion of thorax
1.6
6.3
136
836
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
1.6
6.3
154
979
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
1.8
6.3
93
509
SPAT1325
SPAT
Vaccination
1.2
6.3
1080
9338
R06.2
ICD-10 Finland
Wheezing
1.7
6.3
132
803
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.4
6.3
335
2499
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.1
6.3
67
324
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.3
6.3
473
3719
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
1.8
6.3
106
609
D01AC02
ATC
miconazole; topical
1.5
6.3
225
1559
3718X
ICD-9 Finland
Corneal opacity and other disorders of cornea, Other corneal disorders
18.0
6.3
9
5
3604
FHL
Penetration of the cornea
18.0
6.3
9
5
N99
ICPC
Neurological disease other
2.6
6.3
41
156
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
2.5
6.2
43
170
05404
ICD-8 Finland
Herpes simplex, Meningoencephalitis herpetica
+∞
6.2
6
*
D84.1
ICD-10 Finland
Defects in the complement system
+∞
6.2
6
*
0543A
ICD-9 Finland
Herpes simplex, Herpetic meningoencephalitis[MENINGITIS HERPETICA]
+∞
6.2
6
*
G05.1*B01.1
ICD-10 Finland
Varicella encephalitis
+∞
6.2
6
*
G03.1
ICD-10 Finland
Chronic meningitis
+∞
6.2
6
*
G63.0*B02.29
ICD-10 Finland
Postherpetic polyneuropathy
+∞
6.2
6
*
05300
ICD-8 Finland
Herpes zoster, Opthalmicus
+∞
6.2
6
*
D06
ICPC
Abdominal pain localized other
1.4
6.2
249
1764
J01CA08
ATC
pivmecillinam; oral
1.2
6.2
1452
12915
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.4
6.2
246
1739
N06AA10
ATC
nortriptyline; systemic
2.0
6.2
71
352
A05
ICPC
Feeling ill
1.5
6.2
185
1230
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.1
6.2
64
304
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.2
6.2
959
8207
3700A
ICD-9 Finland
Keratitis, Corneal ulcer
26.7
6.2
8
*
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.6
6.2
162
1045
A02BA04
ATC
nizatidine; systemic
1.5
6.2
226
1571
WX140
NOMESCO Finland
Parabulbar anesthesy
1.7
6.2
114
668
S01
ICPC
Pain/tenderness of skin
1.7
6.2
126
763
XF600
NOMESCO Finland
Bloodpressure measurement
1.5
6.2
177
1168
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
1.8
6.2
101
571
D06BB10
ATC
imiquimod; topical
1.6
6.2
141
881
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
2.5
6.2
45
183
S01AA12
ATC
tobramycin; ophthalmic
5.0
6.2
18
36
H11.4
ICD-10 Finland
Other conjunctival vascular disorders and cysts
3.9
6.2
23
59
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
3.8
6.2
24
64
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.5
6.2
183
1221
R04.2
ICD-10 Finland
Haemoptysis
1.9
6.1
84
450
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.8
6.1
103
591
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
2.2
6.1
54
242
S01ED02
ATC
betaxolol; ophthalmic
3.1
6.1
30
96
C08CA13
ATC
lercanidipine; oral
1.4
6.1
345
2596
L12
ICPC
Hand/finger symptom/complaint
1.3
6.1
448
3511
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
12.5
6.1
10
8
CKD20
NOMESCO Finland
Removal of vitreous body substitute
4.0
6.1
22
55
DFF00
NOMESCO Finland
Pure tone audiometry
1.4
6.1
241
1706
M01AC06
ATC
meloxicam; systemic, rectal
1.2
6.1
1227
10776
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
6.0
778
6535
M01AE01
ATC
ibuprofen; systemic, rectal
1.2
6.0
3610
34761
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.4
6.0
345
2602
-44
ICPC
Preventive immunization/medic
1.4
6.0
235
1660
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
10.0
6.0
11
11
L50.0
ICD-10 Finland
Allergic urticaria
1.9
6.0
85
461
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.3
6.0
568
4602
TEA00
NOMESCO Finland
Biopsy of lip
3.0
6.0
31
103

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
488
349
15.43
307.65
1.3
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
201
123
17.00
240.32
1.2
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
168
85
20.44
219.48
1.4
1.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
131
73
18.41
163.59
1.3
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
214
363
6.12
120.86
2.6
2.6
e9/l
1.3
1.2
0.38
144
221
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
175
273
6.61
107.28
2.6
2.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
2760
19726
1.92
104.52
8.8
5.7
e9/l
0.6
0.6
1.11
2489
17091
(3006315) Basophils [#/volume] in Blood
2765
19800
1.92
103.80
8.8
5.8
e9/l
0.0
0.0
0.03
2492
17137
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
174
285
6.29
101.69
2.5
2.2
%
12.6
13.1
0.15
81
135
(3019198) Lymphocytes [#/volume] in Blood
2813
20372
1.90
100.72
8.8
5.8
e9/l
1.9
1.9
0.05
2561
18013
(1175426) CD3 cells/100 lymphocytes in Blood
175
292
6.18
100.39
2.6
2.2
%
75.5
73.1
1.23
168
282
(3013115) Eosinophils [#/volume] in Blood
2824
20502
1.90
100.07
9.2
6.0
e9/l
0.2
0.2
0.54
2557
18048
(42870588) Differential panel, method unspecified - Blood
2020
13169
1.91
99.94
8.7
5.8
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
276
690
4.18
98.99
8.2
5.2
iu/ml
675.7
550.0
0.15
62
96
(3005719) IgG [Mass/volume] in Serum or Plasma
676
2925
2.52
96.23
4.1
2.7
g/l
9.7
10.5
4.60
634
2679
(3022096) Basophils/100 leukocytes in Blood
2533
17944
1.86
94.96
9.1
5.9
%
0.7
0.7
0.33
2407
16741
(21494815) CD4 cells/100 lymphocytes in Specimen
176
313
5.80
94.54
2.6
2.4
%
39.2
44.8
0.48
13
44
(3007853) Bacteria identified in Skin by Aerobe culture
913
4550
2.24
94.04
2.0
1.7
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
2600
18622
1.85
93.55
9.5
6.2
%
8.6
8.4
1.02
2480
17456
(3006504) Eosinophils/100 leukocytes in Blood
2586
18517
1.85
92.86
9.2
5.9
%
2.8
2.8
0.09
2457
17246
(3013650) Neutrophils [#/volume] in Blood by Automated count
3030
22893
1.86
90.37
14.0
8.8
e9/l
4.1
4.0
0.07
2739
20019
(3002030) Lymphocytes/100 leukocytes in Blood
2642
19229
1.82
88.07
9.2
5.9
%
27.9
28.5
2.02
2515
17944
(3018010) Neutrophils/100 leukocytes in Blood
2604
18959
1.80
85.81
8.8
5.8
%
57.1
56.9
0.30
2490
17748
(3023368) Bacteria identified in Blood by Culture
1547
9625
1.89
85.15
6.2
4.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
537
2293
2.51
77.80
2.3
1.9
g/l
1.1
1.4
4.10
498
2102
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
144
257
5.74
77.02
2.5
2.8
e6/l
530.0
521.3
0.06
114
219
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
209
526
4.11
74.12
4.3
2.7
u/ml
34138.5
1423.6
0.47
16
35
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
137
249
5.63
71.86
2.6
2.8
e9/l
0.2
0.2
0.44
115
218
(3028679) Herpes simplex virus Ab [Presence] in Serum
126
216
5.96
70.27
1.2
1.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3619
29981
1.81
68.13
11.4
7.2
u/l
78.2
77.2
0.50
3437
28255
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2620
19917
1.68
66.91
8.9
5.9
umol/l
10.8
11.2
0.79
2487
18852
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
134
261
5.25
65.16
2.8
2.7
e6/l
682.7
700.3
0.08
48
110
(3024561) Albumin [Mass/volume] in Serum or Plasma
2214
16208
1.67
64.45
6.8
4.6
g/l
35.1
35.8
6.24
2059
15090
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1002
5850
1.90
64.36
2.3
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
132
264
5.11
62.29
1.2
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
109
188
5.91
60.41
1.2
1.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
739
3984
2.01
59.62
6.4
4.1
u/l
244.7
245.4
0.04
698
3761
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
150
355
4.33
57.67
1.5
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2438
18727
1.60
55.41
10.1
6.3
mmol/l
1.2
1.2
0.86
2070
15800
(3013826) Glucose [Moles/volume] in Serum or Plasma
2818
22417
1.61
55.26
6.6
4.5
mmol/l
6.6
6.6
0.61
2656
20796
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
247
850
3.01
53.97
2.2
1.6
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
81
116
7.08
53.74
2.5
2.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1243
8121
1.71
53.34
1.8
1.4
g/l
2.2
2.3
0.83
825
5042
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
105
201
5.32
52.06
1.2
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
241
836
2.98
51.91
2.2
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
527
2633
2.12
51.85
2.3
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
710
3949
1.93
51.79
2.1
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
2292
17528
1.58
51.76
14.3
9.0
e9/l
0.0
0.0
0.47
1946
14298
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
167
464
3.69
51.47
2.2
1.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
89
148
6.11
51.20
2.4
2.1
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
88
145
6.16
51.09
2.6
2.4
%
11.4
10.1
0.40
80
138
(3013707) Erythrocyte sedimentation rate by Westergren method
3486
29486
1.64
50.69
5.6
3.9
mm/h
12.8
11.5
6.10
3268
27406
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
263
971
2.81
50.52
1.5
1.4
mg/l
568.1
504.9
1.18
254
916
(3017181) Myelocytes/100 leukocytes in Blood
600
3174
2.02
50.52
5.7
4.0
%
1.0
0.8
0.49
220
830
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
710
3985
1.92
50.30
2.2
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
193
606
3.28
49.23
2.3
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1330
9055
1.65
47.89
6.8
4.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
877
5337
1.78
47.71
2.4
2.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2197
16913
1.55
46.35
9.0
5.7
mmol/l
1.2
1.2
0.83
2047
15326
(3044290) Cell count panel - Cerebral spinal fluid
224
797
2.90
46.06
1.6
1.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
234
853
2.83
46.01
1.4
1.4
mmol/l
3.5
3.7
1.83
224
797
(3018418) pH of Serum or Plasma
1553
11068
1.59
45.97
6.4
3.8
ph
7.4
7.4
0.46
356
2105
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
234
854
2.83
45.91
1.6
1.5
e6/l
47.4
26.7
1.09
198
661
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
234
855
2.82
45.81
1.7
1.6
e6/l
321.5
1548.8
2.29
204
697
(3003458) Phosphate [Moles/volume] in Serum or Plasma
789
4724
1.80
45.11
9.3
5.6
mmol/l
1.1
1.0
0.35
743
4397
(3000060) B lymphocytes [#/volume] in Blood
72
110
6.63
45.00
2.6
2.4
e6/l
238.4
216.5
0.17
43
62
(3005322) IgE [Units/volume] in Serum or Plasma
511
2660
2.03
44.75
1.7
1.3
u/ml
1079.5
197.3
3.12
469
2463
(3028433) Virus identified in Specimen by Culture
74
118
6.35
44.39
1.2
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1930
14551
1.54
44.08
10.1
8.4
inr
1.2
1.2
2.02
643
4309
(3031040) Bacteria [#/volume] in Urine by Automated count
3127
26153
1.55
44.01
5.6
4.3
e6/l
2355.5
1487.9
0.30
41
331
(3021440) Promyelocytes/100 leukocytes in Blood
560
3030
1.96
43.89
5.8
4.1
%
0.1
0.2
0.07
203
766
(3000850) Epithelial cells [#/volume] in Urine
1177
7917
1.64
43.83
3.6
2.5
e6/l
6.1
6.3
0.20
1064
6923
(3037467) Urinalysis macro (dipstick) panel - Urine
3246
27390
1.56
43.75
5.7
4.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
138
379
3.72
43.27
2.2
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
1815
13609
1.53
41.92
5.0
3.5
e6/l
63.9
101.0
2.07
1355
9440
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1547
11207
1.56
41.75
2.4
2.1
u/l
206.6
212.6
0.06
1456
10535
(3012095) Magnesium [Moles/volume] in Serum or Plasma
932
5976
1.69
41.46
5.4
3.3
mmol/l
0.8
0.8
1.99
880
5564
(3002179) Metamyelocytes/100 leukocytes in Blood
535
2905
1.95
41.38
5.5
3.9
%
0.5
0.6
0.36
160
610
(3010375) cycloSPORINE [Mass/volume] in Blood
79
144
5.56
41.35
36.0
21.3
ug/l
119.2
114.4
0.24
68
113
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1638
12041
1.54
41.28
3.1
2.5
u/l
56.2
57.6
0.40
1516
11129
(3030467) Casts [#/volume] in Urine by Automated count
1459
10466
1.56
40.97
4.3
3.0
e6/l
0.4
0.4
0.17
1167
7847
(3000494) Fungus identified in Specimen by Culture
751
4558
1.77
40.65
1.7
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
524
2844
1.94
40.55
3.7
2.6
e9/l
71.3
70.4
0.22
402
2128
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
178
601
3.04
40.18
1.9
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
663
3903
1.81
39.73
4.2
2.6
%
1.9
1.8
1.14
606
3437
(3018677) aPTT in Platelet poor plasma by Coagulation assay
874
5571
1.69
39.56
2.6
2.2
s
29.7
29.7
0.05
856
5397
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1265
8846
1.58
39.43
2.1
1.8
mg/l
1.1
1.1
0.15
958
6685
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
92
201
4.65
39.16
3.6
2.5
%
41.4
41.7
0.04
32
67
(3021601) Nitrite [Presence] in Urine by Test strip
2429
19528
1.49
39.15
6.0
4.7
estimate
0.0
0.0
0.80
559
3666
(3025159) Blasts/100 leukocytes in Blood
523
2873
1.92
38.97
5.7
4.1
%
0.0
0.3
0.91
167
653
(3035350) Ketones [Presence] in Urine by Test strip
2418
19459
1.48
38.54
4.5
3.5
estimate
0.0
0.0
1.08
553
3594
(46235355) HIV 1 and 2 tests - Meaningful Use set
1205
8373
1.58
38.44
2.1
1.9
—
—
—
0
0
(3026782) Osmolality of Urine
1079
7306
1.61
38.37
3.9
2.7
mosm/kgh2o
526.2
542.5
1.72
975
6211
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
300
1344
2.31
38.34
2.3
1.9
ug/l
1.2
1.7
0.50
274
1194
(36304419) Bacteria [Presence] in Urine
1423
10283
1.54
38.10
4.2
2.9
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
906
5884
1.66
38.03
3.1
2.4
umol/l
12.8
13.4
1.76
855
5449
(3002582) Erythrocytes [#/volume] in Urine
1547
11398
1.52
37.80
4.5
3.1
e6/l
49.3
92.7
1.47
1262
8676
(3009261) Glucose [Presence] in Urine by Test strip
2441
19727
1.48
37.79
4.5
3.5
estimate
0.0
0.0
1.82
541
3590
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1817
13848
1.50
37.72
4.0
3.4
ng/l
37.7
87.1
0.74
1202
8719
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
96
224
4.35
37.64
1.9
1.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
4378
40250
1.87
37.53
22.2
12.9
mg/l
21.3
22.5
1.68
3642
31576
(3026008) Bacteria identified in Urine by Culture
1561
11599
1.51
36.31
3.7
3.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2280
18304
1.46
35.76
3.5
2.9
ug/l
145.4
108.8
5.29
2137
17082
(40758558) Short blood count panel - Blood
1375
10002
1.52
35.14
10.1
6.7
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
58
92
6.37
34.99
1.2
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1692
12857
1.48
34.94
4.0
3.2
mmol/l
2.3
2.4
1.79
1484
11343
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
85
193
4.46
34.52
1.6
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1346
9777
1.52
34.52
3.9
2.4
umol/l
4156.2
4385.7
0.07
1183
8560
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2077
16484
1.45
34.00
2.7
2.2
nmol/l
76.8
76.5
0.27
1925
14984
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
266
1199
2.29
33.47
2.0
1.6
g/l
0.2
0.2
0.45
250
1128
(3004789) Transferrin [Mass/volume] in Serum or Plasma
825
5390
1.64
33.39
3.1
2.4
g/l
2.3
2.4
0.99
777
4986
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
774
4988
1.66
33.04
3.2
2.5
%
22.2
23.1
1.09
681
4275
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
272
1245
2.25
33.00
2.0
1.6
g/l
1.2
1.2
0.24
254
1173
(3020630) Protein [Mass/volume] in Serum or Plasma
495
2816
1.84
32.85
3.1
2.5
g/l
65.0
66.7
4.30
457
2583
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
127
396
3.27
32.81
1.9
1.7
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
534
3121
1.80
32.42
11.5
7.2
mmol/l
9.6
9.3
0.52
512
2981
(4062490)
128
409
3.19
31.77
1.4
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
127
404
3.20
31.76
1.7
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
759
4922
1.64
31.49
1.8
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1330
9791
1.49
31.42
2.6
2.2
mg/l
3.0
2.9
0.97
1173
8382
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
133
447
3.03
30.31
1.9
1.4
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
125
406
3.13
30.20
1.4
1.4
g/l
0.4
0.4
0.49
92
289
(3028192) IgG subclass 2 [Mass/volume] in Serum
125
406
3.13
30.20
1.4
1.4
g/l
2.9
2.9
0.02
93
290
(3027135) IgG subclass 1 [Mass/volume] in Serum
125
407
3.13
30.08
1.4
1.4
g/l
6.5
6.8
0.24
93
289
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
196
810
2.48
29.98
1.6
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
202
847
2.44
29.94
1.3
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
135
461
2.98
29.92
1.9
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
322
1635
2.04
29.89
1.3
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
280
1350
2.14
29.83
1.3
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
194
800
2.48
29.81
1.3
1.2
u/ml
271.6
259.4
0.18
134
491
(3024980) IgG subclass 4 [Mass/volume] in Serum
168
647
2.65
29.73
1.6
1.7
g/l
0.8
0.8
0.08
127
497
(3004588) Protein electrophoresis panel - Serum or Plasma
412
2283
1.88
29.62
3.0
2.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
95
263
3.66
29.52
2.2
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
189
774
2.50
29.48
4.8
3.7
%
55.3
57.4
1.13
189
774
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
242
1108
2.25
29.32
2.7
2.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1298
9628
1.47
29.12
3.3
3.0
ng/l
1601.3
1328.6
1.05
1123
8167
(3037522) Nuclear Ab [Titer] in Serum
834
5636
1.58
28.95
1.5
1.3
titre
662.9
538.0
0.81
171
1166
(3042111) Morphology [Interpretation] in Bone marrow Narrative
150
553
2.77
28.90
2.6
1.6
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
306
1547
2.04
28.74
1.7
1.5
u/ml
16.1
16.4
—
8
38
(3021447) Carbon dioxide [Partial pressure] in Venous blood
536
3248
1.73
28.55
5.9
3.9
kpa
5.8
5.8
0.05
526
3144
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
156
595
2.68
28.15
1.1
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1904
15251
1.41
27.81
2.1
1.9
pmol/l
98.0
96.6
0.63
1046
7868
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1263
9403
1.46
27.53
1.3
1.3
u/ml
1.8
1.7
0.08
340
2577
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
191
813
2.40
27.40
1.6
1.4
—
22.1
—
0
18
(3002032) Base excess in Venous blood by calculation
530
3240
1.71
27.30
6.0
3.9
mmol/l
2.0
1.9
0.25
440
2600
(3048689) Calprotectin [Mass/mass] in Stool
765
5131
1.58
27.29
2.7
2.3
ug/g
136.4
122.8
0.49
601
4073
(3029937) Albumin [Presence] in Urine by Test strip
1373
10412
1.44
27.06
5.1
3.9
estimate
0.0
0.0
1.49
544
3576
(3045142) Bone marrow Pathology biopsy report
115
380
3.08
27.02
1.7
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
412
2351
1.82
26.91
1.4
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
141
524
2.74
26.77
1.9
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
1150
8461
1.47
26.48
1.6
1.5
nmol/l
20.4
20.6
0.19
1036
7294
(3036481) Cortisol [Moles/volume] in Serum or Plasma
592
3762
1.65
26.29
2.5
2.1
nmol/l
351.3
374.8
2.14
553
3454
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3540
31674
1.43
26.07
4.5
4.1
pmol/l
14.6
14.7
0.82
3284
29064
(3037692) Legionella sp identified in Specimen by Organism specific culture
55
110
5.05
26.05
1.5
1.4
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
56
114
4.96
26.00
1.5
2.1
u/ml
888.6
23999.3
—
10
21
(3000991) Gas panel - Venous blood
483
2929
1.72
25.55
9.4
8.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
121
425
2.89
25.54
1.1
1.1
—
3.9
—
0
6
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
972
6966
1.49
25.39
1.8
1.6
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
254
1257
2.08
25.26
1.9
1.7
titre
340.4
366.5
0.04
13
55
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
174
738
2.41
25.18
1.7
1.4
u/ml
103.2
112.6
0.52
36
151
(3033658) Prothrombin time (PT) actual/Normal
1286
9763
1.43
24.79
5.3
3.8
%
91.7
92.0
0.13
1242
9502
(3023103) Potassium [Moles/volume] in Serum or Plasma
4354
40784
1.64
24.31
23.2
14.5
mmol/l
3.9
4.0
0.34
4262
39651
(3021879) Hepatitis B virus core Ab [Presence] in Serum
512
3199
1.67
24.18
1.6
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
178
778
2.34
24.08
1.9
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
220
1050
2.15
24.05
1.9
1.7
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
50
99
5.09
23.97
1.2
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1647
13127
1.38
23.72
4.3
3.1
u/l
33.2
34.5
0.25
1559
12492
(3022145) Colonoscopy Study observation
636
4218
1.58
23.57
1.4
1.3
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
62
149
4.20
23.50
37.6
33.3
ug/l
7.1
7.5
0.74
55
137
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
32
42
7.66
22.92
1.9
1.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
138
549
2.56
22.92
4.4
3.3
%
1.0
1.5
1.42
115
425
(3023410) Appearance of Cerebral spinal fluid
109
384
2.88
22.92
1.8
1.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
771
5371
1.52
22.85
1.2
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
54
119
4.58
22.84
1.2
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
105
364
2.93
22.73
2.1
1.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
4333
40653
1.60
22.67
22.9
14.4
mmol/l
139.5
139.7
6.22
4247
39603
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1851
15114
1.36
22.64
4.8
3.6
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
231
1150
2.06
22.61
3.4
2.7
g/l
3.6
3.6
0.12
221
1087
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1101
8245
1.43
22.53
1.8
1.6
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
492
3108
1.65
22.20
7.5
6.8
mmol/l
1.3
1.3
0.01
477
2998
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
78
232
3.40
21.83
1.6
1.5
u/ml
20.8
19.2
0.13
19
50
(3008536) Aspergillus sp Ab [Presence] in Serum
40
71
5.67
21.61
2.6
2.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
137
559
2.49
21.60
1.2
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
165
732
2.30
21.59
1.7
1.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
285
1553
1.89
21.50
1.7
1.8
g/l
1.5
1.5
0.12
247
1336
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
878
6367
1.46
21.18
3.4
2.6
e6/l
1.1
1.2
0.60
521
3588
(44790049)
110
410
2.72
20.84
2.1
1.4
—
—
—
0
0
(44790047)
110
410
2.72
20.84
2.1
1.4
—
—
—
0
0
(44790048)
110
410
2.72
20.84
2.1
1.4
—
—
—
0
0
(44806118)
110
410
2.72
20.84
2.1
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1189
9143
1.40
20.65
4.3
3.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
911
6690
1.45
20.49
1.8
1.7
nmol/l
1218.2
1167.4
0.76
699
5095
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4009
37183
1.44
20.32
5.4
4.8
mu/l
2.3
2.0
0.29
3751
34401
(3014576) Chloride [Moles/volume] in Serum or Plasma
646
4436
1.53
20.31
8.2
6.8
mmol/l
104.2
104.4
0.52
636
4340
(3024354) Oxygen [Partial pressure] in Venous blood
432
2705
1.66
20.12
4.9
3.3
kpa
4.6
4.6
0.28
425
2610
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
206
1029
2.05
20.00
1.5
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
65
182
3.61
19.97
2.2
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
65
182
3.61
19.97
2.2
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
643
4429
1.52
19.90
4.5
2.6
umol/l
9.2
7.7
0.70
570
3811
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
80
257
3.15
19.80
1.3
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
113
440
2.61
19.66
3.1
2.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
70
208
3.40
19.65
2.1
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
49
113
4.37
19.62
2.6
3.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
3120
27858
1.33
19.59
3.6
3.2
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
27
35
7.75
19.54
1.9
1.5
mg/l
1.8
1.5
0.11
17
23
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
199
998
2.04
19.12
6.2
3.9
mg/l
1.7
1.4
2.53
189
924
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
939
7012
1.42
19.12
4.2
3.5
ng/l
320.5
381.0
0.22
679
5104
(40767503) Oxygen content in Capillary blood by calculation
161
745
2.20
19.07
3.1
2.4
%
15.9
16.2
0.28
77
368
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
435
2769
1.63
18.95
4.6
3.7
ng/l
89.2
84.7
0.46
369
2399
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
289
1651
1.80
18.73
2.1
1.9
u/l
40.7
39.3
0.54
259
1493
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
26
34
7.68
18.67
1.9
1.4
mg/l
2.2
3.8
0.64
17
20
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
26
34
7.68
18.67
1.9
1.4
mg/l
2.0
2.9
0.26
16
19
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
26
34
7.68
18.67
1.9
1.4
mg/l
3.1
1.2
0.55
15
24
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
26
34
7.68
18.67
1.9
1.4
mg/l
1.0
0.9
0.08
18
21
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
26
34
7.68
18.67
1.9
1.4
mg/l
1.2
1.1
0.08
15
22
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
26
34
7.68
18.67
1.9
1.4
mg/l
2.5
2.1
0.09
17
23
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
26
34
7.68
18.67
1.9
1.4
mg/l
2.0
2.5
0.18
18
24
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
26
34
7.68
18.67
1.9
1.4
mg/l
0.9
1.3
0.37
18
24
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
26
34
7.68
18.67
1.9
1.4
mg/l
1.3
1.9
0.25
16
19
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4014
37389
1.42
18.50
18.8
11.8
ml/min/173m2
83.7
83.9
0.27
3449
30752
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
47
110
4.30
18.49
1.2
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
524
3515
1.55
18.25
2.8
2.2
g/l
0.2
0.2
0.82
482
3295
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
32
54
5.96
18.21
1.4
1.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
282
1622
1.78
17.86
4.9
3.2
mmol/l
25.1
25.2
0.29
275
1565
(4035726)
497
3312
1.56
17.81
1.6
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
111
451
2.50
17.72
2.5
2.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
99
381
2.63
17.67
1.1
1.1
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
578
3998
1.51
17.42
7.6
7.3
kpa
5.0
5.1
0.92
554
3811
(3027801) Oxygen [Partial pressure] in Arterial blood
578
3998
1.51
17.42
7.6
7.3
kpa
12.1
12.5
1.29
555
3812
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
538
3671
1.52
17.29
3.0
2.4
u/l
35.2
51.6
0.67
467
3149
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4476
42711
1.60
17.24
15.1
9.7
u/l
26.4
26.0
0.54
4355
41306
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
900
6792
1.40
17.03
3.4
2.9
mmol/l
2.5
2.4
0.79
776
5955
(40761536) Microorganisms panel - Urine sediment
504
3402
1.54
17.02
5.1
3.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
575
3992
1.50
17.00
7.6
7.3
mmol/l
1.1
1.1
0.14
439
3093
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
25
35
7.17
16.94
1.4
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
156
748
2.12
16.93
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
156
748
2.12
16.93
1.4
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
463
3071
1.56
16.91
7.0
3.6
mmol/l
1.2
1.2
3.18
427
2657
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
199
1043
1.95
16.90
2.0
2.0
mg/l
10.0
11.1
1.04
182
970
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
432
2823
1.58
16.84
2.3
2.3
au/ml
16.2
23.9
1.11
17
178
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
53
146
3.66
16.72
1.2
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
549
3788
1.51
16.71
4.7
3.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
519
3548
1.52
16.51
7.9
7.7
%
95.4
95.8
0.70
506
3414
(3041096) Erythrocytes [Presence] in Urine by Automated
1330
10720
1.33
16.44
4.1
3.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
164
811
2.06
16.41
5.2
4.1
mmol/l
2.3
2.6
1.06
113
536
(3013290) Carbon dioxide [Partial pressure] in Blood
164
812
2.06
16.36
5.2
4.1
kpa
4.9
5.0
2.31
164
801
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
54
153
3.56
16.36
3.6
3.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1931
16391
1.30
16.32
2.2
2.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
796
5922
1.41
16.30
3.7
2.7
e6/l
3.1
3.0
0.12
440
3161
(3022806) Fractional oxyhemoglobin in Capillary blood
111
470
2.39
16.24
2.4
1.8
%
89.7
89.8
0.06
111
464
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
17
15
11.37
16.20
2.9
2.5
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
164
817
2.04
16.09
5.2
4.2
kpa
9.0
8.6
1.24
164
805
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
43
105
4.12
16.04
1.2
1.0
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
184
962
1.95
15.76
1.6
1.4
iu/ml
8.5
15.6
—
9
23
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2165
18708
1.28
15.72
5.0
3.9
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
23
32
7.22
15.66
1.3
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
42
104
4.06
15.39
1.2
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
3660
33881
1.32
15.27
24.8
15.6
%
13.8
13.6
6.71
3597
33160
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
142
684
2.11
15.26
1.7
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3017
27228
1.28
15.24
3.8
3.0
u/l
48.4
44.7
1.40
2854
25552
(3044640) Blood type and Crossmatch panel - Blood
1507
12474
1.30
15.12
3.1
2.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
926
7145
1.37
15.11
1.4
1.3
iu/ml
33.4
30.7
0.20
268
2269
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
81
307
2.67
14.96
2.1
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
81
307
2.67
14.96
2.1
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
81
307
2.67
14.96
2.1
1.7
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
43
111
3.90
14.91
1.2
1.0
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
107
465
2.33
14.80
7.0
6.6
mg/l
11.7
11.6
0.08
100
433
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
340
2166
1.61
14.72
1.7
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
227
1300
1.78
14.62
3.2
2.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
227
1300
1.78
14.62
3.2
2.3
g/l
3.9
3.8
0.30
172
939
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
227
1301
1.78
14.58
3.2
2.3
g/l
7.3
7.4
0.47
179
981
(3003327) Ova and parasites identified in Stool by Light microscopy
236
1372
1.76
14.44
1.8
1.7
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
331
2107
1.61
14.38
5.3
3.2
g/l
127.0
129.3
1.09
323
2045
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
263
1578
1.70
14.38
4.4
2.8
%
0.7
0.7
0.80
253
1511
(3026389) Candida sp identified in Specimen by Organism specific culture
123
574
2.17
14.36
1.4
1.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
214
1213
1.80
14.27
3.3
2.3
g/l
10.2
10.3
0.10
186
1037
(3013005) Retinol [Moles/volume] in Serum or Plasma
55
173
3.20
14.20
1.8
1.8
umol/l
2.1
1.9
0.57
47
161
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
214
1220
1.79
14.01
3.3
2.4
g/l
3.1
3.1
0.20
174
963
(3044889) 12 lead EKG panel
2978
26968
1.27
13.95
4.1
3.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1021
8082
1.33
13.94
1.7
1.6
pmol/l
50457060.5
31239394.3
0.37
876
6796
(3012516) Albumin [Mass/volume] in Urine
1270
10373
1.30
13.84
3.9
3.2
mg/l
340.9
365.1
0.07
829
6462
(40761535) Cells panel - Urine sediment
448
3083
1.50
13.74
4.7
3.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
271
1661
1.67
13.69
1.3
1.2
u/ml
2.1
1.1
0.29
18
156
(3019060) Gas panel - Arterial blood
350
2285
1.57
13.67
5.0
5.0
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
265
1616
1.68
13.64
4.4
2.8
%
1.2
1.3
0.78
265
1600
(3037756) Immunofixation for Serum or Plasma
135
669
2.05
13.50
1.8
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
221
1286
1.75
13.49
2.4
1.7
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
27
52
5.22
13.41
1.3
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1381
11449
1.29
13.33
4.1
3.2
mmol/l
7.5
7.5
0.01
1190
9692
(40760888) Immunoglobulin light chains.free panel - Serum
148
762
1.97
13.31
4.5
3.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
200
1136
1.79
13.27
1.2
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
133
662
2.04
13.15
1.2
1.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
183
1018
1.83
13.01
4.4
3.3
mg/l
61.1
112.9
0.42
139
835
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
194
1100
1.80
12.95
3.9
2.3
g/l
1.6
0.8
1.28
176
965
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
277
1732
1.64
12.95
6.9
4.4
mmol/l
24.1
24.1
0.01
250
1565
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
38
100
3.82
12.86
1.2
1.1
—
—
—
0
0
(3010421) pH of Blood
175
965
1.84
12.80
5.2
4.0
ph
7.4
7.4
0.42
165
800
(3024932) HLA-DR beta [Type]
42
119
3.55
12.79
1.3
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
207
1201
1.76
12.78
2.6
2.3
ug/l
385.3
644.1
0.68
192
1118
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
423
2920
1.49
12.76
2.3
2.3
ug/l
6.5
6.7
0.04
356
2565
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1159
9439
1.30
12.73
2.8
2.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
123
603
2.07
12.68
2.2
1.4
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
57
196
2.93
12.68
1.6
1.3
%
82.5
65.3
1.19
21
23
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
182
1019
1.82
12.68
4.4
3.3
mg/l
55.2
60.0
0.08
137
837
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
42
120
3.52
12.63
1.6
1.1
%
14.4
19.3
0.23
19
13
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
176
980
1.83
12.48
3.4
2.2
g/l
0.0
0.0
0.43
167
908
(3024471) HLA-A [Type]
42
121
3.49
12.48
1.0
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
155
829
1.90
12.48
1.5
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
204
1190
1.75
12.37
1.3
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
205
1198
1.74
12.35
1.3
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
4402
42240
1.44
12.35
18.8
12.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
341
2270
1.54
12.22
5.5
3.5
kpa
5.1
5.2
1.52
318
2116
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
165
907
1.85
12.21
3.5
2.3
g/l
0.0
0.0
0.00
156
846
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
166
915
1.84
12.17
3.5
2.3
g/l
0.0
0.0
0.00
157
847
(3000093) Morphology [Interpretation] in Blood Narrative
79
328
2.43
12.17
1.2
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
215
1279
1.71
12.16
1.6
1.6
iu/ml
0.1
5.4
0.62
43
271
(3009343) pH of Capillary blood
337
2244
1.54
12.06
5.5
3.5
ph
7.4
7.4
2.66
51
270
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
201
1178
1.74
12.00
1.3
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
98
450
2.20
11.97
1.2
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
180
1023
1.79
11.95
3.3
2.2
g/l
37.5
37.8
0.28
163
888
(3002173) Hemoglobin [Mass/volume] in Arterial blood
462
3288
1.45
11.91
8.5
8.1
g/l
119.7
121.9
1.61
451
3165
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
318
2097
1.55
11.89
1.8
1.6
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
175
989
1.80
11.84
4.2
3.2
ratio
1.9
2.1
0.12
15
82
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
61
229
2.68
11.57
1.2
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
857
6779
1.32
11.52
1.4
1.3
u/ml
12.4
11.3
0.16
321
2734
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
153
837
1.85
11.51
1.3
1.2
u/ml
1.8
3.0
0.37
16
61
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
325
2171
1.53
11.47
5.5
3.5
mmol/l
1.3
1.8
1.51
249
1621
(3023183) Ammonium ion [Moles/volume] in Plasma
141
753
1.90
11.43
3.8
2.8
umol/l
38.5
35.6
0.52
126
645
(3020682) Albumin/Creatinine [Ratio] in Urine
1306
10922
1.27
11.41
4.6
4.0
mg/mmol
11.8
8.7
0.99
860
6861
(3020891) Body temperature
229
1410
1.65
11.40
4.7
4.6
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
13
13
10.02
11.33
1.3
1.2
—
—
—
0
0
(4010399)
383
2659
1.48
11.23
1.5
1.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
101
482
2.12
11.22
2.2
1.7
titre
384.0
1200.0
—
5
16
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
196
1164
1.71
11.18
1.3
1.2
u/ml
22.8
38.5
0.64
14
75
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
127
662
1.94
11.08
1.1
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
100
478
2.11
11.07
2.3
2.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
183
1071
1.74
11.01
1.3
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
38
112
3.41
10.94
5.4
4.9
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
29
73
3.99
10.47
1.7
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1036
8499
1.28
10.47
4.8
3.9
kg/l
1.0
1.0
0.11
142
1294
(3039162) Centromere protein B Ab [Units/volume] in Serum
101
496
2.06
10.44
1.4
1.3
u/ml
73.2
42.4
—
7
31
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
425
3052
1.43
10.43
2.8
2.5
ml/min/173m2
61.2
68.4
3.22
194
1192
(3013512) EKG study
1256
10550
1.26
10.41
4.3
3.6
—
—
—
0
0
(3000012) Reticulocyte production index
50
179
2.81
10.41
1.6
1.5
—
—
—
0
0
(3036489) Thrombin time
231
1464
1.61
10.27
2.6
2.2
s
21.6
21.3
0.21
203
1253
(3052851) Hemolysis interference index of Serum or Plasma
186
1119
1.69
10.15
3.3
3.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
31
84
3.71
10.12
1.1
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
178
1061
1.70
10.05
1.4
1.2
u/ml
16.6
6.3
0.51
26
110
(3037121) Protein [Mass/volume] in Urine
207
1284
1.64
10.05
4.8
3.1
g/l
0.5
0.3
0.43
116
522
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
153
875
1.77
10.00
1.3
1.2
u/ml
24.8
45.5
1.15
17
94
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
194
1189
1.66
9.87
1.4
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
73
323
2.28
9.82
3.9
3.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
648
5033
1.33
9.80
2.2
2.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
63
262
2.42
9.75
1.3
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
142
801
1.80
9.74
5.1
3.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
220
1403
1.59
9.55
2.2
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
183
1115
1.67
9.54
4.6
3.3
u/ml
0.4
0.4
0.07
111
644
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
178
1077
1.68
9.53
1.4
1.3
u/ml
14.0
7.2
0.57
35
173
(3000492) Spirometry study
510
3843
1.37
9.41
1.6
1.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
124
680
1.85
9.33
1.2
1.1
au/ml
16.7
12.6
—
8
43
(3028626) Oxygen [Partial pressure] in Capillary blood
144
828
1.76
9.27
6.4
3.3
kpa
8.5
8.3
0.48
138
768
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
51
197
2.61
9.22
1.3
1.3
titre
86.7
67.8
—
6
18
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
49
186
2.65
9.17
2.3
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
49
186
2.65
9.17
2.3
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
49
186
2.65
9.17
2.3
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
49
186
2.65
9.17
2.3
1.9
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
18
34
5.31
9.15
1.2
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
63
270
2.35
9.14
1.4
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
115
620
1.88
9.14
3.3
2.8
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
23
54
4.27
9.11
1.3
1.1
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
41
142
2.90
9.10
1.1
1.1
ng/l
475.4
369.8
0.12
14
32
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
181
1114
1.65
9.09
3.2
2.7
%
187.2
184.7
0.14
172
1063
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
63
273
2.32
8.93
1.4
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
4622
45066
1.51
8.91
30.7
19.1
e9/l
255.0
256.2
0.53
4532
44012
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
706
5623
1.30
8.86
2.2
2.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
63
274
2.32
8.86
1.1
1.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
315
2207
1.46
8.83
7.5
7.1
mmol/l
24.2
24.5
0.48
305
2050
(3010813) Leukocytes [#/volume] in Blood
4624
45099
1.51
8.79
30.6
19.1
e9/l
6.8
6.7
2.28
4528
43915
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
26
69
3.78
8.77
1.1
1.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
4624
45104
1.50
8.73
30.8
19.2
g/l
133.1
135.0
16.13
4571
44503
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
23
56
4.12
8.70
6.7
5.9
—
—
—
0
0
(3024731) MCV [Entitic volume]
4622
45086
1.50
8.67
30.5
19.0
fl
91.1
90.7
6.09
4568
44494
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
34
109
3.13
8.63
1.3
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
4622
45093
1.50
8.58
30.6
19.0
e12/l
4.4
4.5
16.49
4525
43921
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
62
272
2.30
8.56
1.1
1.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
265
1806
1.49
8.55
9.7
9.3
mmol/l
24.1
24.3
0.60
243
1692
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
206
1332
1.57
8.47
1.4
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
79
385
2.07
8.41
4.3
4.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
177
1106
1.62
8.40
1.5
1.4
ug/g
261.0
289.3
1.07
105
611
(3035941) MCH [Entitic mass]
4620
45086
1.49
8.38
30.5
19.0
pg
30.3
30.2
2.49
4566
44491
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
193
1237
1.58
8.25
3.0
2.4
%
93.7
92.5
0.29
181
1145
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
232
1551
1.52
8.22
2.5
1.9
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
29
88
3.31
8.05
1.3
1.3
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
11
14
7.87
7.99
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
11
14
7.87
7.99
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
11
14
7.87
7.99
1.0
1.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
144
866
1.68
7.95
4.0
3.1
mmol/l
24.2
25.0
1.53
130
756
(3006922) Hepatitis E virus Ab [Presence] in Serum
63
288
2.20
7.92
1.1
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
89
464
1.94
7.88
1.6
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
573
4506
1.31
7.88
23.0
22.8
inr
1.3
1.3
0.01
90
653
(40768446) Kidney Pathology biopsy report
39
143
2.74
7.85
2.4
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
89
465
1.93
7.83
1.6
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
591
4673
1.30
7.80
1.8
1.7
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
36
127
2.85
7.78
3.0
1.8
ug/l
62.2
52.9
0.30
36
121
(3005988) Vibrio sp identified in Specimen by Organism specific culture
89
467
1.92
7.74
1.6
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
444
3377
1.35
7.70
1.2
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
69
331
2.10
7.69
1.3
1.1
mg/l
52.1
39.8
1.14
60
278
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
90
478
1.90
7.56
1.6
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3757
35779
1.22
7.55
6.1
5.3
mmol/mol
39.6
39.2
1.67
3503
33325
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
40
152
2.65
7.53
2.3
2.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
73
363
2.03
7.41
1.4
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
74
371
2.01
7.35
3.6
3.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
46
191
2.42
7.24
1.1
1.1
miu/ml
1717.6
1454.7
0.66
46
191
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
64
307
2.10
7.17
1.2
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
20
51
3.93
7.15
1.1
1.0
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
209
1416
1.50
7.00
5.7
5.4
%
1.6
1.7
0.17
199
1319
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
87
471
1.86
6.93
1.6
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
87
473
1.85
6.84
1.6
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
150
949
1.60
6.84
1.4
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
111
651
1.72
6.78
1.6
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
102
584
1.76
6.77
1.3
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
362
2723
1.36
6.77
3.3
3.4
pmol/l
4.4
4.5
0.73
321
2442
(3022313) Gas panel - Capillary blood
236
1651
1.45
6.73
5.9
3.6
—
—
—
0
0
(3013862) HLA-DP [Type]
10
14
7.16
6.69
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
10
14
7.16
6.69
1.0
1.0
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
376
2855
1.34
6.61
3.7
2.9
ng/l
166.7
186.0
0.42
334
2581
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
43
181
2.39
6.60
9.0
6.0
u/ml
44.6
59.2
0.42
12
40
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1165
10108
1.20
6.59
1.7
1.6
mmol/l
1.5
1.4
1.63
994
8557
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
38
151
2.53
6.58
2.4
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
38
151
2.53
6.58
2.4
2.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
17
41
4.16
6.54
4.2
2.4
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
19
50
3.81
6.52
1.2
1.2
u/ml
0.0
0.0
—
10
28
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
19
50
3.81
6.52
1.1
1.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3982
38290
1.22
6.50
4.6
4.2
mmol/l
5.9
5.9
1.06
3677
35204
(3004716) Salmonella sp identified in Stool by Organism specific culture
304
2239
1.38
6.50
1.4
1.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
20
55
3.65
6.46
1.5
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
122
744
1.66
6.46
1.1
1.1
u/ml
5.0
1.8
0.73
34
185
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
15
33
4.56
6.45
4.9
2.4
mg/l
0.9
1.3
0.59
15
21
(3035637) Corticotropin [Mass/volume] in Plasma
88
490
1.81
6.43
2.0
1.5
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
38
4.22
6.28
1.1
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
23
71
3.25
6.27
1.3
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
23
71
3.25
6.27
1.3
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
23
71
3.25
6.27
1.3
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
167
1107
1.53
6.24
1.3
1.2
titre
120.6
115.2
0.04
16
96
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
61
304
2.02
6.22
1.2
1.2
titre
563.8
193.5
—
8
65
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
99
577
1.73
6.21
1.2
1.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
203
1404
1.47
6.17
5.9
5.4
%
0.9
0.9
0.61
193
1311
(3008295) Osmolality of Serum or Plasma
73
390
1.89
6.10
1.2
1.4
mosm/kgh2o
279.9
279.2
0.11
60
300
(3003888) Timothy IgE Ab [Units/volume] in Serum
129
816
1.60
5.94
1.1
1.1
u/ml
8.1
5.2
0.88
79
422
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
36
147
2.46
5.93
2.6
3.2
mg/l
9.2
7.8
0.57
26
122
(3008401) Mugwort IgE Ab [Units/volume] in Serum
125
785
1.61
5.93
1.1
1.1
u/ml
2.8
1.3
0.63
71
335
(3002256) Pathology report gross observation
619
5089
1.25
5.91
1.3
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
16
40
4.01
5.89
2.6
3.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
422
3317
1.30
5.83
2.2
1.9
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
70
376
1.87
5.78
1.2
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
255
1863
1.39
5.75
11.6
10.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
18
50
3.61
5.75
1.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
53
259
2.06
5.73
1.3
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
116
722
1.62
5.72
4.9
2.7
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
63
329
1.93
5.66
1.5
1.5
%
31.9
32.8
0.06
40
205
(3004451) EKG impression Narrative
39
169
2.32
5.66
1.4
1.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
166
1125
1.49
5.62
6.7
6.4
mmol/l
1.2
1.3
0.18
150
987
(3051651) Icteric interference index of Serum or Plasma
47
221
2.14
5.62
4.0
3.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
134
868
1.56
5.59
1.7
1.7
e6/l
17062.9
12316.8
0.36
105
621
(4027681)
52
257
2.03
5.47
1.3
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
34
141
2.42
5.44
1.1
1.0
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
251
1847
1.38
5.44
3.6
2.7
e6/l
0.3
0.3
0.34
242
1788
(3018405) Lactate [Moles/volume] in Arterial blood
182
1267
1.45
5.40
3.8
3.9
mmol/l
1.4
1.4
0.18
182
1248
(3025130) Human papilloma virus identified in Specimen
103
633
1.64
5.36
1.6
1.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
58
301
1.94
5.33
1.2
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
461
3707
1.27
5.33
4.3
4.0
ug/l
90.9
24.1
0.46
371
2935
(3009542) Hematocrit [Volume Fraction] of Blood
3898
37577
1.19
5.32
20.7
13.8
%
39.4
39.8
2.53
2835
28121
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
203
1448
1.42
5.29
6.3
3.7
mmol/l
24.5
24.9
1.02
186
1353
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
62
331
1.88
5.25
3.3
2.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
390
3078
1.29
5.24
1.3
1.2
iu/ml
123.4
155.8
0.41
144
1170
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
17
49
3.48
5.16
1.0
1.0
u/ml
0.2
0.1
0.25
12
28
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
34
145
2.35
5.14
3.9
3.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
77
444
1.75
5.09
1.3
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
48
237
2.04
5.09
1.2
1.1
u/l
1.1
1.1
0.14
16
118
(3017354) Segmented neutrophils/100 leukocytes in Blood
63
342
1.85
5.08
4.5
3.5
%
59.1
57.5
0.16
40
226
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
56
293
1.92
5.05
1.9
1.3
u/ml
3.1
1.0
0.81
33
122
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
229
1682
1.38
5.04
1.1
1.1
—
1.6
—
0
23
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
101
629
1.62
5.02
1.2
1.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
43
205
2.11
5.00
1.4
1.4
nmol/l
1.2
1.2
0.22
31
164
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
136
908
1.51
4.99
1.2
1.1
u/ml
3.1
1.4
0.84
74
357
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
64
352
1.83
4.96
1.1
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
15
41
3.67
4.92
1.2
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
547
4529
1.23
4.89
1.5
1.4
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
26
100
2.61
4.88
1.7
1.9
u/l
56.5
47.2
0.10
21
93
(3011897) Casein IgE Ab [Units/volume] in Serum
20
67
2.99
4.82
1.4
1.3
u/ml
52.9
0.9
—
9
13
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
19
62
3.07
4.78
1.2
1.1
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
9
10
9.01
4.78
5.3
2.9
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
9
10
9.01
4.78
5.3
2.9
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
120
788
1.54
4.77
2.5
2.2
g/l
125.5
129.1
0.75
87
575
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
172
1215
1.43
4.76
1.0
1.1
u/ml
5.3
4.3
0.14
17
161
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
17
52
3.28
4.74
1.0
1.1
%
66.7
53.2
0.63
12
22
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
332
2605
1.29
4.69
2.1
1.8
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
18
58
3.11
4.63
4.3
2.7
—
24.7
—
0
13
(3046861) Legionella sp Ag [Presence] in Urine
9
11
8.19
4.56
1.0
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
10
21
4.77
4.53
7.2
4.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
22
81
2.72
4.50
1.3
1.0
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
112
735
1.54
4.49
3.9
2.9
mmol/l
1.4
1.6
1.01
106
710
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
13
35
3.72
4.36
1.8
1.3
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
31
138
2.25
4.30
1.1
1.1
%
93.9
91.6
—
9
65
(3017569) Oxygen content in Arterial blood
36
171
2.11
4.27
2.1
2.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
67
393
1.71
4.24
5.7
6.1
mmol/l
6.9
7.3
0.53
61
330
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
33
152
2.18
4.23
1.4
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
33
152
2.18
4.23
1.2
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
23
90
2.56
4.21
1.3
1.2
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
80
493
1.63
4.21
2.2
1.5
mu/l
75.4
47.7
0.37
73
436
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
16
51
3.14
4.20
1.5
1.4
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
13
36
3.62
4.20
1.1
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
13
36
3.62
4.20
1.2
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
167
1203
1.40
4.19
4.6
3.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
14
41
3.42
4.18
1.4
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
85
533
1.61
4.17
1.0
1.1
g/l
1.5
1.5
0.06
79
482
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
260
2009
1.31
4.15
2.6
2.2
u/l
7152.3
5621.3
0.29
105
782
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
30
134
2.25
4.14
1.1
1.2
%
94.8
91.8
—
9
63
(3017704) Immunofixation for Urine
38
188
2.03
4.07
1.7
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
131
908
1.45
4.07
1.3
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
105
696
1.52
4.06
1.2
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
209
1574
1.34
4.00
1.1
1.1
—
—
—
0
0
(3019225) pH of Specimen
447
3706
1.23
3.97
6.0
4.0
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
35
170
2.07
3.95
1.4
2.5
umol/l
98.1
147.7
0.70
17
96
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
12
33
3.64
3.92
1.1
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
19
70
2.72
3.91
1.6
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
17
59
2.89
3.89
1.7
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
104
696
1.51
3.86
1.2
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
70
427
1.65
3.86
1.6
1.6
%
51.4
58.4
0.76
46
269
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
30
140
2.15
3.76
1.1
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
164
1208
1.37
3.65
2.7
2.5
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
30
142
2.12
3.64
3.4
2.5
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
16
56
2.86
3.62
1.4
1.5
ng/l
107.2
117.0
0.16
16
56
(3003181) Sodium [Moles/volume] in Urine
91
601
1.52
3.62
1.3
1.4
mmol/l
66.3
65.0
0.12
75
485
(3028707) Methadone [Presence] in Urine by Screen method
112
773
1.46
3.60
4.0
3.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
56
329
1.71
3.58
1.2
1.4
e6/l
69454.3
84233.3
0.08
47
232
(1001926) Buprenorphine [Presence] in Urine by Screen method
184
1385
1.34
3.57
3.7
2.3
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
15
51
2.95
3.57
4.7
3.5
umol/l
37.8
41.3
0.27
15
41
(3047007) Chlamydophila sp Ab [Presence] in Serum
94
629
1.50
3.53
1.3
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
118
827
1.44
3.51
3.1
2.4
ug/min
157.1
92.9
0.84
70
498
(3034274) Bile acid [Moles/volume] in Serum --fasting
92
614
1.51
3.50
1.6
2.2
umol/l
10.1
7.2
0.29
63
444
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1016
9125
1.14
3.48
4.6
4.7
ug/l
2.4
3.2
0.84
915
8183
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
30
145
2.08
3.46
1.2
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
78
504
1.56
3.44
1.4
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
34
173
1.97
3.43
2.3
2.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
34
173
1.97
3.43
2.3
2.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
147
1077
1.38
3.40
4.2
4.2
mmol/l
3.8
3.9
0.48
140
1009
(40763480) Human metapneumovirus Ag [Presence] in Specimen
9
18
5.01
3.37
1.2
1.6
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
15
53
2.84
3.35
1.8
1.5
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
16
59
2.72
3.32
1.1
1.1
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
16
59
2.72
3.32
1.4
1.2
ng/l
25.9
72.7
—
8
42
(3016879) Cocaine [Presence] in Urine
212
1648
1.30
3.30
3.4
2.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
228
1792
1.29
3.27
3.3
2.0
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
6
7
8.58
3.26
1.0
1.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
196
1511
1.31
3.25
1.2
1.3
miu/ml
197.1
226.2
0.53
84
726
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
45
256
1.76
3.24
1.0
1.1
nmol/l
1.8
6.3
—
6
55
(3023323) Follitropin [Units/volume] in Serum or Plasma
289
2345
1.25
3.19
1.4
1.3
iu/l
28.2
28.2
0.00
243
2008
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
14
49
2.86
3.18
1.2
1.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
7
11
6.37
3.18
1.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
228
1799
1.28
3.18
3.4
2.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
176
1342
1.32
3.17
1.8
1.8
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
21
91
2.31
3.16
1.3
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
869
7774
1.14
3.14
1.5
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
51
304
1.68
3.13
2.6
1.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
62
389
1.60
3.13
3.3
2.4
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
99
690
1.44
3.08
4.2
3.0
mmol/l
7.5
7.5
0.08
94
669
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
22
99
2.23
3.05
1.1
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
223
1765
1.28
3.05
3.2
2.2
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
7
12
5.84
3.02
1.0
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
52
316
1.65
2.99
1.3
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
52
316
1.65
2.99
1.3
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
52
316
1.65
2.99
1.3
1.2
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
29
147
1.98
2.99
1.7
1.2
g/l
0.3
0.3
1.24
24
116
(3023430) Cat dander IgE Ab [Units/volume] in Serum
86
587
1.47
2.99
1.1
1.1
u/ml
10.0
4.1
1.22
39
232
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
5
5
10.01
2.98
1.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
48
286
1.69
2.97
1.6
1.4
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
79
531
1.50
2.96
1.1
1.1
u/ml
4.3
0.3
0.99
21
122
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
33
176
1.88
2.94
1.1
1.1
u/l
107.1
79.1
0.71
25
138
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
33
176
1.88
2.94
1.1
1.1
u/l
35.0
22.7
0.69
23
133
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
166
1271
1.32
2.93
4.1
3.5
u/ml
163.1
4051.0
1.06
139
1072
(3000764) Benzodiazepines [Presence] in Urine
224
1784
1.27
2.92
3.4
2.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
119
866
1.38
2.92
5.5
4.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
143
1072
1.34
2.91
1.9
2.0
iu/l
3.6
4.5
0.82
50
409
(3039000) Anion gap in Blood
109
782
1.40
2.91
8.4
7.6
mmol/l
11.7
11.2
0.74
100
697
(3016750) Collection duration of Urine
38
213
1.79
2.91
3.3
2.1
min
529.6
496.3
1.43
26
158
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
33
177
1.87
2.90
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
52
319
1.64
2.89
1.3
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
52
319
1.64
2.89
1.3
1.2
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
109
783
1.40
2.89
8.4
7.6
mmol/l
105.4
105.2
0.16
100
698
(3010838) Calcium [Moles/time] in 24 hour Urine
36
199
1.82
2.88
1.5
1.7
—
8.0
—
0
15
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
52
320
1.63
2.86
1.3
1.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
62
400
1.56
2.82
3.3
2.4
mmol/l
105.9
105.3
0.52
62
393
(3041354) Potassium [Moles/volume] in Venous blood
62
400
1.56
2.82
3.3
2.4
mmol/l
4.1
4.0
0.58
62
393
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
22
103
2.14
2.80
1.4
1.4
nmol/l
136.8
133.5
0.03
17
75
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
17
71
2.40
2.79
2.7
2.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
27
137
1.98
2.79
1.7
1.8
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
12
42
2.86
2.74
1.4
1.2
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
27
138
1.96
2.74
1.1
1.1
u/ml
0.2
2.2
1.49
15
71
(3020393) Adenovirus Ag [Presence] in Stool
13
48
2.71
2.71
2.2
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
90
633
1.43
2.71
1.3
1.2
u/ml
4.1
3.8
0.06
34
217
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
19
85
2.24
2.70
1.5
1.5
ug/l
0.3
0.4
—
10
52
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
280
2310
1.23
2.69
1.1
1.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
69
461
1.50
2.69
1.3
1.4
pmol/l
304.1
291.7
0.12
53
359
(3010937) Rubella virus Ab [Presence] in Serum
9
24
3.75
2.67
1.2
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
46
280
1.65
2.66
1.0
1.0
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
58
374
1.56
2.66
1.1
1.2
u/l
55.2
59.3
0.24
43
257
(21494890) Protein electrophoresis panel - 24 hour Urine
52
327
1.60
2.65
3.2
1.8
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
25
126
1.99
2.65
1.4
1.2
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
28
147
1.91
2.64
6.8
6.1
mg/l
66.0
72.7
0.22
22
105
(4094501)
132
995
1.34
2.63
1.1
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
51
320
1.60
2.63
1.2
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
139
1057
1.32
2.61
1.4
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
84
588
1.44
2.61
1.5
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
339
3997
0.84
2.59
1.8
1.7
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
46
283
1.63
2.57
3.0
2.2
ml
783.6
627.6
2.09
30
193
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
5
7
7.15
2.55
1.0
1.0
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
6
11
5.46
2.54
1.0
1.1
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
6
11
5.46
2.54
1.0
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
10
33
3.03
2.52
2.0
3.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
90
643
1.41
2.51
1.1
1.1
u/ml
13.2
2.9
2.73
40
243
(3012441) Differential panel - Pleural fluid
52
332
1.57
2.51
1.6
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
69
469
1.48
2.50
1.4
1.3
nmol/l
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
52
333
1.57
2.48
1.2
1.3
nmol/l
1.5
1.5
0.00
45
301
(3020123) Porphyrins [Interpretation] in Serum or Plasma
9
26
3.47
2.48
1.2
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4077
39945
1.13
2.47
5.0
4.5
mmol/l
2.8
2.8
3.82
3790
37065
(3045414) Leukocytes [Presence] in Urine
220
1789
1.24
2.45
2.1
1.9
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
33
188
1.76
2.44
1.9
2.2
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
30
166
1.81
2.44
1.6
1.5
%
2.7
4.0
—
7
35
(3045424) Erythrocytes [Presence] in Urine
92
664
1.39
2.43
1.7
1.6
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
34
2.95
2.41
1.3
1.0
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
76
531
1.44
2.41
1.5
1.3
nmol/l
0.1
0.4
—
6
27
(3019977) pH of Arterial blood
33
189
1.75
2.40
2.6
2.9
ph
7.4
7.4
0.01
14
63
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
194
1560
1.25
2.39
1.6
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
107
794
1.36
2.39
1.7
1.3
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
45
281
1.61
2.39
1.1
1.1
u/ml
30.1
1.0
0.69
24
88
(40765096) Chromosome analysis panel by Banding
23
118
1.95
2.35
1.3
1.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
100
737
1.36
2.34
4.0
3.4
u/ml
272.1
686.6
0.49
89
679
(3005011) Chlamydia sp Ab [Titer] in Serum
15
65
2.31
2.31
1.5
1.6
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
85
612
1.40
2.30
1.3
1.3
u/ml
3.1
4.6
1.24
44
263
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
35
207
1.70
2.29
1.2
1.2
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
6
13
4.62
2.27
1.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
70
488
1.44
2.26
1.5
1.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
53
349
1.52
2.26
1.5
1.5
e6/l
10006.7
80682.3
2.38
27
214
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
64
439
1.46
2.25
2.2
2.2
mg/l
31.2
22.0
0.64
20
108
(3036603) Volume of Urine
39
239
1.64
2.25
1.6
1.4
ml
1598.8
2031.2
—
8
48
(40757494) Bilirubin.total [Moles/volume] in Blood
34
201
1.70
2.24
2.3
2.5
umol/l
84.7
31.1
—
5
19
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
9
5.56
2.21
1.0
1.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
283
2389
1.20
2.20
2.4
2.1
nmol/l
12.2
12.2
0.01
235
2102
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
11
42
2.62
2.18
2.5
1.9
mg/l
2.0
1.4
0.56
11
36
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
15
67
2.24
2.17
2.0
2.2
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
25
136
1.84
2.17
1.1
1.0
u/ml
27.8
4.8
—
7
16
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
6
14
4.29
2.15
1.0
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
7
19
3.69
2.15
22.0
5.3
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
21
108
1.95
2.15
1.7
1.6
%
5.9
3.5
0.41
15
96
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4010
39324
1.11
2.13
4.6
4.1
mmol/l
4.7
4.7
2.95
3753
36731
(3009466) Valproate [Moles/volume] in Serum or Plasma
79
570
1.39
2.13
4.7
5.4
umol/l
332.4
371.4
1.57
70
493
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
30
174
1.73
2.12
1.5
1.6
nmol/l
9.3
7.1
0.12
22
137
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
127
986
1.30
2.12
1.4
1.2
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
24
130
1.85
2.12
3.6
2.6
umol/l
34.6
28.7
0.70
18
90
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
103
777
1.33
2.11
2.7
2.1
nmol/l
0.8
0.8
0.51
82
653
(3024928) Oxygen saturation in Venous blood
100
752
1.34
2.09
6.2
3.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
42
268
1.57
2.08
1.7
1.5
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
37
229
1.62
2.07
1.2
1.2
mmol/l
30.2
34.7
0.58
31
200
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
40
254
1.58
2.03
1.4
1.6
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
11
44
2.50
2.01
1.0
1.0
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
62
435
1.43
1.98
1.7
1.5
g/l
32.4
32.8
0.09
55
393
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3845
37666
1.10
1.97
4.2
3.7
mmol/l
1.3
1.3
3.15
3574
34819
(3017315) Amylase [Enzymatic activity/volume] in Urine
31
186
1.67
1.97
1.2
1.3
u/l
222.9
304.6
0.62
26
172
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
517
4616
1.13
1.96
9.9
6.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3980
39055
1.10
1.96
4.5
4.1
mmol/l
1.5
1.5
1.00
3710
36315
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
36
225
1.60
1.96
1.6
1.6
u/l
11.9
5.7
0.82
23
114
(21494755) Public health laboratory ask at order entry panel
385
4385
0.87
1.96
1.3
1.3
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
6
16
3.75
1.93
1.0
1.3
—
—
—
0
0
(44813793)
44
290
1.52
1.92
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
50
339
1.48
1.91
1.5
1.3
titre
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
26
150
1.74
1.90
1.3
1.2
g/l
—
0.3
—
0
10
(3033923) Metanephrine [Moles/time] in 24 hour Urine
16
79
2.03
1.85
1.0
1.1
umol/24h
0.7
0.7
—
5
42
(3036071) Salmonella sp Ab [Titer] in Serum
26
152
1.71
1.83
1.0
1.1
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
5
12
4.17
1.82
5.8
3.8
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
33
206
1.61
1.82
1.3
1.4
nmol/l
135.7
131.7
0.15
33
206
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
792
7281
1.10
1.81
4.0
4.1
%
22.1
21.6
0.43
359
3401
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
31
191
1.63
1.80
1.0
1.1
u/ml
29.3
6.4
—
10
28
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
232
1965
1.19
1.79
2.4
2.4
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
8
29
2.76
1.79
1.0
1.0
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
42
280
1.50
1.76
1.1
1.1
u/ml
8.3
0.9
0.53
18
73
(3021387) Prolactin [Units/volume] in Serum or Plasma
199
1666
1.20
1.75
1.7
1.6
mu/l
273.5
295.7
0.79
176
1494
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
29
177
1.64
1.75
1.2
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
309
2686
1.16
1.75
1.2
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
45
305
1.48
1.74
1.2
1.1
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
6
18
3.34
1.74
1.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
9
36
2.50
1.74
1.1
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
8
30
2.67
1.72
1.6
1.7
umol/l
46.4
44.3
—
8
30
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
5
13
3.85
1.71
1.2
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
221
1873
1.19
1.71
4.4
3.2
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
19
103
1.85
1.71
1.2
1.4
umol/l
16.7
17.2
0.26
19
92
(1002224) Polysomnography panel
200
1680
1.20
1.71
1.1
1.1
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
11
48
2.29
1.70
1.5
1.7
%
4.6
7.8
—
5
28
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
85
647
1.32
1.70
1.1
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
23
133
1.73
1.69
1.3
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
38
251
1.52
1.67
1.8
1.7
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
34
219
1.56
1.67
1.2
1.3
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
6
19
3.16
1.66
1.0
1.2
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
7
25
2.80
1.65
1.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
7
25
2.80
1.65
1.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
14
69
2.03
1.64
1.1
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
16
83
1.93
1.64
1.1
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
557
5057
1.11
1.63
1.9
1.7
%
1.5
1.4
1.15
494
4504
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
183
1533
1.20
1.63
1.8
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1235
11638
1.08
1.62
1.6
1.5
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
5
14
3.57
1.61
1.2
1.8
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
20
113
1.77
1.60
1.1
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
8
32
2.50
1.59
1.3
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
33
214
1.55
1.59
1.4
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
14
70
2.00
1.59
2.1
2.9
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
26
159
1.64
1.58
1.2
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
26
159
1.64
1.58
1.2
1.4
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
6
20
3.00
1.58
1.0
2.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
323
2842
1.15
1.57
2.9
2.7
e9/l
4.2
4.1
0.31
259
2275
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
33
215
1.54
1.56
1.2
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
13
64
2.03
1.54
1.5
1.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
61
450
1.36
1.52
1.2
1.3
—
37.0
—
0
5
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
5
15
3.34
1.52
6.2
5.8
umol/l
677.2
406.5
—
5
15
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
7
27
2.59
1.51
2.6
2.2
mg/l
2.7
3.0
—
7
27
(3022621) pH of Urine by Test strip
295
2591
1.15
1.49
3.0
2.9
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
15
79
1.90
1.49
1.3
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
44
309
1.43
1.47
1.6
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
99
788
1.26
1.45
1.6
1.7
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
41
285
1.44
1.45
2.1
2.0
u/field
1.6
1.8
0.11
22
123
(3009214) Lutropin [Units/volume] in Serum or Plasma
146
1213
1.21
1.45
1.5
1.3
u/l
11.6
10.6
0.32
112
998
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
6
22
2.73
1.43
3.0
1.4
pmol/l
22.1
30.7
—
6
17
(4306422)
82
639
1.29
1.43
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
236
2711
0.86
1.42
1.4
1.4
—
—
—
0
0
(4034850)
155
1299
1.20
1.41
9.6
9.2
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
36
246
1.47
1.39
1.1
1.0
u/ml
0.5
3.2
—
8
34
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
13
67
1.94
1.38
1.6
1.7
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
12
60
2.00
1.38
2.2
2.6
ml/dl
14.2
14.9
0.44
12
54
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
20
119
1.68
1.37
1.6
1.5
ug/l
10.1
8.4
0.51
20
119
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
26
166
1.57
1.37
2.6
2.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
268
2357
1.15
1.35
2.7
3.2
u/ml
41.9
54.7
0.55
260
2274
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
521
4768
1.10
1.34
1.8
1.8
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
34
232
1.47
1.33
1.6
1.6
u/l
5.1
6.8
1.20
29
200
(3017509) Phencyclidine [Presence] in Urine
9
42
2.14
1.33
1.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
68
524
1.30
1.31
1.1
1.3
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
9
43
2.10
1.30
1.1
1.0
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
5
18
2.78
1.28
2.8
3.4
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
13
69
1.89
1.28
1.1
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
9
44
2.05
1.26
1.7
1.6
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
21
130
1.62
1.26
1.6
1.5
%
53.8
62.2
0.48
16
110
(3023199) Leukocytes [#/volume] in Pleural fluid
53
397
1.34
1.25
1.6
1.5
e6/l
1724.8
2170.5
0.28
35
295
(3026692) Albumin [Mass/volume] in Peritoneal fluid
16
92
1.74
1.24
1.3
1.5
g/l
13.1
13.0
0.02
11
68
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
9
45
2.00
1.23
1.2
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
10
49
2.04
1.22
1.5
1.5
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
8
37
2.16
1.21
1.0
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
13
71
1.83
1.19
1.2
1.4
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
8
38
2.11
1.18
1.0
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
77
613
1.26
1.18
1.1
1.1
%
123.4
117.5
0.91
68
556
(4268621)
55
419
1.32
1.17
2.3
2.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
84
679
1.24
1.14
1.5
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
32
224
1.43
1.14
2.8
3.9
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
88
716
1.23
1.13
1.4
1.4
nmol/l
0.3
0.4
2.41
71
569
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
49
370
1.33
1.12
1.5
1.4
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
10
51
1.96
1.11
1.1
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
7
31
2.26
1.10
3.1
2.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
26
176
1.48
1.10
1.1
1.1
iu/ml
190.7
183.4
0.06
26
176
(3020491) Glucose [Moles/volume] in Blood
40
294
1.36
1.09
1.5
1.9
mmol/l
6.3
6.6
0.39
30
197
(3013945) Hepatitis B virus e Ab [Presence] in Serum
5
21
2.38
1.09
1.0
2.0
—
—
—
0
0
(3035880) pH of Pleural fluid
27
185
1.46
1.08
1.2
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
35
253
1.39
1.06
1.5
1.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
80
650
1.23
1.05
1.0
1.1
u/ml
2.9
3.4
0.20
35
314
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
5
22
2.27
1.03
1.2
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
5
22
2.27
1.03
1.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
47
1.92
1.02
1.1
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
9
47
1.92
1.02
1.1
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
25
171
1.46
1.02
1.7
2.1
ug/min
15.4
169.9
—
5
39
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
29
206
1.41
0.98
1.3
1.9
—
—
—
0
0
(4024509)
48
370
1.30
0.98
1.5
1.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
23
156
1.48
0.98
1.1
1.1
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
9
160
0.56
0.97
1.3
2.3
nmol/l
105.7
154.0
—
9
143
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
36
1.95
0.97
1.0
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
16
100
1.60
0.96
1.1
1.2
g/l
38.6
37.6
—
7
58
(3038177) Helicobacter pylori Ab [Presence] in Serum
84
697
1.21
0.93
1.3
1.2
—
—
—
0
0
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
6
27
2.22
0.93
2.0
2.3
—
23.9
—
0
10
(4198724)
27
192
1.41
0.92
1.8
4.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
6
28
2.14
0.91
1.7
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
188
1669
1.13
0.90
1.4
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
15
94
1.60
0.90
1.4
2.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
8
42
1.91
0.88
1.0
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
7
129
0.54
0.87
3.0
3.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
8
43
1.86
0.87
1.4
1.0
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
15
229
0.65
0.87
1.0
1.0
ng/l
804.1
710.8
—
8
153
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
36
273
1.32
0.85
1.1
1.1
iu/ml
4.8
9.6
—
9
75
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
13
80
1.63
0.84
1.5
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
69
569
1.22
0.84
1.5
1.6
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
73
607
1.21
0.82
3.1
3.0
nmol/l
0.8
0.8
0.28
54
451
(3008116) Ketones [Moles/volume] in Urine by Test strip
12
73
1.65
0.81
1.5
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
44
346
1.27
0.81
1.5
1.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
112
969
1.16
0.80
1.9
1.7
nmol/l
36.9
41.4
0.95
112
938
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
21
147
1.43
0.80
1.1
1.3
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
8
48
1.67
0.78
32.1
12.3
mmol/l
4.5
5.9
—
8
48
(3034092) Cytoplasmic Ig cells/100 cells in Blood
8
48
1.67
0.78
12.3
9.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
6
34
1.77
0.76
2.8
2.6
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
6
34
1.77
0.76
1.0
1.1
u/ml
—
1.1
—
0
19
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
16
107
1.50
0.76
2.1
2.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
16
107
1.50
0.76
2.1
2.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
559
5276
1.07
0.75
2.9
2.9
ug/l
0.7
0.8
0.47
382
3378
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
24
2.08
0.74
1.0
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
3542
34986
1.05
0.72
26.1
16.4
g/l
332.1
332.4
0.70
3516
34718
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
16
230
0.69
0.72
1.0
1.0
ng/l
33.9
46.8
—
9
153
(3044009) aPTT.lupus sensitive (LA screen)
7
40
1.75
0.71
1.1
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
16
109
1.47
0.70
1.8
1.5
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
16
228
0.70
0.69
1.0
1.0
ng/l
251.0
332.5
—
9
155
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
13
85
1.53
0.68
1.1
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
92
1059
0.87
0.68
1.5
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
76
649
1.17
0.67
1.1
1.1
iu/ml
91.9
14458.4
0.53
14
162
(3047189) Immunofixation for 24 hour Urine
21
153
1.37
0.67
2.8
1.5
—
—
—
0
0
(3001729) Color of Synovial fluid
5
28
1.79
0.66
1.0
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
25
188
1.33
0.66
1.7
2.0
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
39
313
1.25
0.64
1.5
1.5
promille
1.0
1.1
0.27
34
240
(3047352) Trisomy 18 risk [Likelihood] in Fetus
93
1064
0.87
0.64
1.6
1.4
—
—
—
0
0
(4015189)
13
87
1.50
0.63
1.6
2.4
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
53
442
1.20
0.62
1.2
1.1
%
99.1
95.9
0.38
47
418
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
23
173
1.33
0.61
3.1
2.3
umol/l
55.3
53.5
0.13
18
144
(3037556) Urate [Mass/volume] in Serum or Plasma
6
105
0.57
0.61
2.2
1.3
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
86
749
1.15
0.61
1.4
1.4
u/l
21.4
25.8
0.83
68
621
(3001019) Free T4 and TSH panel - Serum or Plasma
232
2513
0.92
0.61
1.8
1.7
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
8
50
1.60
0.61
1.0
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
27
346
0.78
0.61
1.5
1.5
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
32
401
0.80
0.60
1.5
1.6
mmol/l
7.4
7.7
0.17
20
248
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.5
—
18.2
—
0
22
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
19
140
1.36
0.58
2.4
2.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
37
300
1.24
0.58
2.9
3.2
%
11.7
11.2
0.36
37
300
(42529582) MDA5 Ab [Presence] in Serum by Line blot
13
89
1.46
0.58
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
13
89
1.46
0.58
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
13
89
1.46
0.58
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
13
89
1.46
0.58
1.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
50
419
1.20
0.57
1.1
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
12
81
1.48
0.57
1.4
1.2
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
16
115
1.39
0.56
1.4
2.1
e6/l
989.1
20275.9
—
8
66
(3043410) Blood group antigens tested for on Red Blood Cells
16
115
1.39
0.56
1.9
1.7
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
37
1.62
0.55
1.3
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
117
1298
0.90
0.53
1.5
1.4
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
39
1.54
0.53
2.0
2.6
u/field
0.8
0.7
—
6
39
(1617658) Protocol used for examination of sentinel lymph nodes
27
338
0.80
0.52
1.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
117
1297
0.90
0.52
1.5
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
12
83
1.45
0.51
1.5
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
15
109
1.38
0.50
1.8
2.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
98
1094
0.89
0.50
1.6
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
121
1096
1.11
0.50
1.9
1.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
40
335
1.20
0.48
1.3
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
33
271
1.22
0.48
1.2
1.2
ratio
1.1
1.0
0.40
17
96
(3032057) Clostridioides difficile [Presence] in Stool
11
76
1.45
0.48
1.9
2.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
7
49
1.43
0.46
3.7
2.8
—
—
—
0
0
(3034426) Prothrombin time (PT)
18
138
1.31
0.45
1.1
1.2
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
26
210
1.24
0.45
1.0
1.1
%
97.1
92.2
0.39
21
163
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
119
1303
0.91
0.44
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
119
1302
0.91
0.44
1.5
1.4
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
17
130
1.31
0.43
1.6
2.3
e6/l
687.8
740.7
0.04
11
98
(44806071)
8
56
1.43
0.42
1.3
1.1
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
8
57
1.40
0.42
1.8
1.9
pmol/l
19.1
30.4
—
8
50
(3039443) Prostate specific Ag panel - Serum or Plasma
51
584
0.87
0.41
1.6
1.6
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(4212803)
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
102
928
1.10
0.41
2.5
2.1
—
—
—
0
0
(3022670) pH of Venous cord blood
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
130
1409
0.92
0.40
1.5
1.5
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.0
—
0.1
—
0
8
(3001686) Cold agglutinin [Titer] in Serum or Plasma
10
71
1.41
0.39
1.1
1.4
—
112.3
—
0
13
(4038314)
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
39
335
1.17
0.38
1.1
1.1
nmol/l
370.5
382.1
0.12
32
299
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
5
36
1.39
0.38
4.8
9.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
63
561
1.12
0.38
1.2
1.2
u/l
26.6
39.0
0.83
57
487
(3051593) INR in Capillary blood by Coagulation assay
12
158
0.76
0.37
14.4
11.3
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
11
81
1.36
0.36
1.4
1.9
mmol/l
0.1
1.3
0.46
11
76
(3050129) First trimester maternal screen panel - Serum or Plasma
175
1642
1.07
0.36
1.5
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
12
90
1.33
0.35
1.8
2.0
umol/l
14.7
17.2
0.49
12
90
(3035320) C reactive protein [Mass/volume] in Body fluid
33
282
1.17
0.35
3.2
2.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
43
1.40
0.35
1.8
2.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
67
604
1.11
0.34
1.3
1.4
mmol/l
7.1
7.2
0.09
47
445
(3025018) Bordetella pertussis Ab [Titer] in Serum
30
255
1.18
0.34
1.1
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
11
82
1.34
0.34
1.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
18
220
0.82
0.32
1.1
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
7
54
1.30
0.30
4.3
2.6
—
—
—
0
0
(4281824)
39
441
0.88
0.29
1.2
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
7
56
1.25
0.29
1.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
22
185
1.19
0.29
2.0
1.8
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
7
57
1.23
0.29
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1459
14812
0.98
0.28
2.9
2.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
21
176
1.19
0.28
2.0
3.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
90
834
1.08
0.28
4.7
3.4
mg/l
31.0
26.2
0.52
62
507
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
73
0.68
0.26
8.8
6.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
73
0.68
0.26
4.4
3.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
10
126
0.79
0.24
1.1
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
100
939
1.07
0.23
1.6
1.5
—
—
—
0
0
(4146454)
40
360
1.11
0.23
2.9
2.7
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
13
106
1.23
0.23
1.7
1.4
—
—
—
0
0
(44806420)
11
88
1.25
0.22
1.5
2.4
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
11
88
1.25
0.22
1.2
1.1
pmol/l
446.2
286.8
0.35
11
60
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
258
2491
1.04
0.22
1.7
1.5
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
42
1.19
0.21
1.0
1.1
umol/24h
1.6
1.6
—
5
42
(3019174) dRVVT (LA screen)
5
42
1.19
0.21
1.2
1.1
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
11
0.00
0.21
0.0
2.8
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.5
—
2.3
—
0
12
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(4133840)
8
102
0.78
0.21
1.1
1.2
—
—
—
0
0
(37019676) Renin [Units/volume] in Plasma --supine
0
13
0.00
0.21
0.0
1.1
—
13.0
—
0
8
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
2.2
—
0
13
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
171
1640
1.04
0.20
1.5
1.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
19
164
1.16
0.20
3.8
2.9
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
48
1.25
0.20
1.8
2.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
170
1633
1.04
0.19
1.9
1.7
mg/l
4.1
3.6
0.20
123
1146
(3035933) Granulocytes/100 leukocytes in Blood
16
137
1.17
0.18
1.9
1.5
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
7
59
1.19
0.18
4.0
7.2
—
—
—
0
0
(4211845)
22
196
1.12
0.16
2.0
3.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
25
275
0.91
0.14
6.4
6.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
103
997
1.03
0.10
1.2
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
19
208
0.91
0.10
1.1
1.3
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
19
174
1.09
0.09
1.3
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
466
4610
1.01
0.08
4.6
4.2
%
32.4
32.5
0.07
336
3162
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
6
71
0.84
0.07
1.0
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
66
643
1.03
0.05
1.2
1.4
ug/l
2.3
4.2
3.02
55
581
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
58
564
1.03
0.05
1.2
1.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
17
181
0.94
0.05
2.3
1.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
56
545
1.03
0.04
1.2
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
24
229
1.05
0.04
1.0
1.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
35
362
0.97
0.04
1.3
1.4
mmol/l
9.5
12.1
1.86
18
80
(3005082) Progesterone [Moles/volume] in Serum or Plasma
28
269
1.04
0.04
1.3
1.3
nmol/l
31.5
32.0
0.04
28
239
(3019897) Erythrocyte distribution width [Ratio] by Automated count
58
592
0.98
0.03
3.5
2.5
%
13.3
13.1
0.25
58
586
(43055514) Macroprolactin [Presence] in Serum or Plasma
12
112
1.07
0.03
1.3
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
14
132
1.06
0.02
1.1
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
122
1233
0.99
0.02
1.6
1.5
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
42
428
0.98
0.01
4.5
4.8
u/ml
346.3
69.7
0.38
12
126
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
24
247
0.97
0.01
1.5
1.4
pmol/l
140.9
171.9
—
8
79
(3000034) Microalbumin [Mass/volume] in Urine
34
342
0.99
0.00
2.9
2.9
mg/l
64.2
36.5
0.38
25
250
(3044007) Cell count panel - Peritoneal fluid
11
107
1.03
0.00
1.5
2.1
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
2.5
—
0
9
(3041184) Isoniazid [Presence] in Urine
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
5
50
1.00
0.00
1.2
1.3
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
8
80
1.00
0.00
21.0
7.8
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.1
—
123.2
—
0
9
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
7
0.00
0.00
0.0
4.6
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
7
72
0.97
0.00
21.4
8.0
—
—
—
0
0
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
8
0.00
0.00
0.0
1.3
—
31.9
—
0
8
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
7
74
0.95
0.00
7.7
7.2
%
71.1
71.3
—
7
61
(3018291) Platelet Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
9
0.00
0.00
0.0
1.2
—
70.6
—
0
9
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008343) Lysozyme [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
0.4
—
0
5
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
214.5
—
0
9
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
9
0.00
0.00
0.0
1.0
—
164.4
—
0
9
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
5
52
0.96
0.00
3.8
2.3
pmol/l
55.9
82.5
—
5
46
(3003157) Bacteria [#/volume] in Mother's milk
0
8
0.00
0.00
0.0
6.5
—
—
—
0
0
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
6
0.00
-0.00
0.0
1.5
—
3462.8
—
0
6
(3049233) Organic acids panel - Urine
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_HERPES_SIMPLEX and mortality.

Females

Parameter HR [95% CI] p-value
AB1_HERPES_SIMPLEX 1.414 [1.26, 1.59] < 0.001
Birth year 0.994 [0.99, 1.0] 0.132

During the follow-up period (1.1.1998 — 31.12.2019), 2089 out of 15898 females with AB1_HERPES_SIMPLEX died.

Males

Parameter HR [95% CI] p-value
AB1_HERPES_SIMPLEX 1.583 [1.4, 1.78] < 0.001
Birth year 0.987 [0.98, 1.0] 0.005

During the follow-up period (1.1.1998 — 31.12.2019), 1872 out of 10705 males with AB1_HERPES_SIMPLEX died.

Mortality risk

Mortality risk for people of age

years, who have AB1_HERPES_SIMPLEX.

N-year risk Females Males
1 0.134% 0.29%
5 0.861% 1.828%
10 2.098% 4.349%
15 3.939% 8.385%
20 6.991% 13.889%

Relationships between endpoints

↥

Index endpoint: AB1_HERPES_SIMPLEX – Herpesviral [herpes simplex] infections

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data